\r\n\t
",isbn:"978-1-83969-108-9",printIsbn:"978-1-83969-107-2",pdfIsbn:"978-1-83969-109-6",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,isSalesforceBook:!1,isNomenclature:!1,hash:"de4ec5bb46fa24bd45d7cc410bd95779",bookSignature:"Dr. Ghedira Kais and Dr. Yosr Hamdi",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/10661.jpg",keywords:"Bioinformatics, Computational Approaches, Databases, Portals, Cancer Registries, E-Health Records, Novel Treatment, Drug Repurposing, Mutations, Biomarkers, Whole Exome Sequencing, Whole Genome Sequencing",numberOfDownloads:464,numberOfWosCitations:0,numberOfCrossrefCitations:1,numberOfDimensionsCitations:1,numberOfTotalCitations:2,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"May 14th 2021",dateEndSecondStepPublish:"July 26th 2021",dateEndThirdStepPublish:"September 24th 2021",dateEndFourthStepPublish:"December 13th 2021",dateEndFifthStepPublish:"February 11th 2022",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"10 months",secondStepPassed:!0,areRegistrationsClosed:!0,currentStepOfPublishingProcess:5,editedByType:null,kuFlag:!1,biosketch:"Dr. Kais Ghedira is an assistant professor at the Institute Pasteur of Tunis (IPT) holding a Ph.D. degree in bioinformatics. He has been involved in several international and national projects funded by European Commission, IPT, and NIH and is mainly devoted to bioinformatics education and training in Africa.",coeditorOneBiosketch:"Dr. Yosr Hamdi obtained her Ph.D. in Molecular Medicine at Laval University, Quebec, Canada. By combining genomics, molecular biology, and bioinformatics, she is implementing Precision Oncology in Africa.",coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"229844",title:"Dr.",name:"Ghedira",middleName:null,surname:"Kais",slug:"ghedira-kais",fullName:"Ghedira Kais",profilePictureURL:"https://mts.intechopen.com/storage/users/229844/images/system/229844.jpg",biography:"Dr. Kais Ghedira is an assistant professor in Institut Pasteur of Tunis (IPT) holding a PhD degree in bioinformatics. He has been involved in several international and national projects funded by European Commission, IPT, and NIH and is mainly involved in bioinformatics education and training in Africa. Dr. Ghedira is a bioinformatician with biological background. He is mainly interested in functional genomics and integrative biology, analysis of NGS high-throughput data (genome assembly, metagenomics), comparative genomics, gene expression (microarrays) and gene regulation analysis, and database and web tools development.",institutionString:"Institut Pasteur de Tunis",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Institut Pasteur de Tunis",institutionURL:null,country:{name:"Tunisia"}}}],coeditorOne:{id:"344524",title:"Dr.",name:"Yosr",middleName:null,surname:"Hamdi",slug:"yosr-hamdi",fullName:"Yosr Hamdi",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000033oAvSQAU/Profile_Picture_1608285761815",biography:"Dr. Hamdi holds a PhD in Molecular Medicine from Laval University, Quebec, she is currently an Assistant Biologist at the Laboratory of Biomedical Genomics and Oncogenetics in Institute Pasteur de Tunis, Tunisia. Her research interests and activities concern: 1- Applications of high throughput sequencing methods in precision medicine; 2- Investigation of breast cancer genetic landscape in North African populations and evaluation of the impact on the response to conventional and targeted therapies; 3- Setting up a web portal and African wide collaborative initiative in precision medicine hosted by the H3Abionet network https://h3abionet.org/; 4- Training activities in genomic medicine for health care providers and consumers in Africa; 5- Community engagement in health care system to handle cancer diseases.",institutionString:"Institut Pasteur de Tunis",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Institut Pasteur de Tunis",institutionURL:null,country:{name:"Tunisia"}}},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"11",title:"Engineering",slug:"engineering"}],chapters:[{id:"79580",title:"Dotting the “i” of Interoperability in FAIR Cancer-Registry Data Sets",slug:"dotting-the-i-of-interoperability-in-fair-cancer-registry-data-sets",totalDownloads:103,totalCrossrefCites:0,authors:[null]},{id:"79550",title:"Urologic Cancer Molecular Biology",slug:"urologic-cancer-molecular-biology",totalDownloads:97,totalCrossrefCites:0,authors:[null]},{id:"79450",title:"Identification of Biomarkers Associated with Cancer Using Integrated Bioinformatic Analysis",slug:"identification-of-biomarkers-associated-with-cancer-using-integrated-bioinformatic-analysis",totalDownloads:158,totalCrossrefCites:1,authors:[null]},{id:"79881",title:"Control of Cytoskeletal Dynamics in Cancer through a Combination of Cytoskeletal Components",slug:"control-of-cytoskeletal-dynamics-in-cancer-through-a-combination-of-cytoskeletal-components",totalDownloads:106,totalCrossrefCites:0,authors:[null]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"185543",firstName:"Maja",lastName:"Bozicevic",middleName:null,title:"Mrs.",imageUrl:"https://mts.intechopen.com/storage/users/185543/images/4748_n.jpeg",email:"maja.b@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"6681",title:"Transcriptional and Post-transcriptional Regulation",subtitle:null,isOpenForSubmission:!1,hash:"d38c85f23360f283586f8a3d3325315a",slug:"transcriptional-and-post-transcriptional-regulation",bookSignature:"Kais Ghedira",coverURL:"https://cdn.intechopen.com/books/images_new/6681.jpg",editedByType:"Edited by",editors:[{id:"229844",title:"Dr.",name:"Ghedira",surname:"Kais",slug:"ghedira-kais",fullName:"Ghedira Kais"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10198",title:"Response Surface Methodology in Engineering Science",subtitle:null,isOpenForSubmission:!1,hash:"1942bec30d40572f519327ca7a6d7aae",slug:"response-surface-methodology-in-engineering-science",bookSignature:"Palanikumar Kayaroganam",coverURL:"https://cdn.intechopen.com/books/images_new/10198.jpg",editedByType:"Edited by",editors:[{id:"321730",title:"Prof.",name:"Palanikumar",surname:"Kayaroganam",slug:"palanikumar-kayaroganam",fullName:"Palanikumar Kayaroganam"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2270",title:"Fourier Transform",subtitle:"Materials Analysis",isOpenForSubmission:!1,hash:"5e094b066da527193e878e160b4772af",slug:"fourier-transform-materials-analysis",bookSignature:"Salih Mohammed Salih",coverURL:"https://cdn.intechopen.com/books/images_new/2270.jpg",editedByType:"Edited by",editors:[{id:"111691",title:"Dr.Ing.",name:"Salih",surname:"Salih",slug:"salih-salih",fullName:"Salih Salih"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"117",title:"Artificial Neural Networks",subtitle:"Methodological Advances and Biomedical Applications",isOpenForSubmission:!1,hash:null,slug:"artificial-neural-networks-methodological-advances-and-biomedical-applications",bookSignature:"Kenji Suzuki",coverURL:"https://cdn.intechopen.com/books/images_new/117.jpg",editedByType:"Edited by",editors:[{id:"3095",title:"Prof.",name:"Kenji",surname:"Suzuki",slug:"kenji-suzuki",fullName:"Kenji Suzuki"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3828",title:"Application of Nanotechnology in Drug Delivery",subtitle:null,isOpenForSubmission:!1,hash:"51a27e7adbfafcfedb6e9683f209cba4",slug:"application-of-nanotechnology-in-drug-delivery",bookSignature:"Ali Demir Sezer",coverURL:"https://cdn.intechopen.com/books/images_new/3828.jpg",editedByType:"Edited by",editors:[{id:"62389",title:"PhD.",name:"Ali Demir",surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"43962",title:"Brainstem Gliomas",doi:"10.5772/53887",slug:"brainstem-gliomas",body:'1. Introduction
Brainstem gliomas are a heterogeneous group of tumors occurring in the brainstem and cervicomedullary junction. They occur more often in children than in adults. Brainstem tumors, according to data prior to early 1980s, represent 10-20% of all central nervous system neoplasms in the pediatric population [1-3]. Approximately 90% of brainstem tumors are gliomas in origin [4].
Diffuse intrinsic pontine glioma (DIPG) is the most common type representing approximately 80% of brainstem gliomas [5, 6]. They have a dismal prognosis with a median survival of only a year. Their natural history is often compared to but worse than that of supratentorial glioblastoma seen primarily in the adult population. Nondiffuse brainstem gliomas, including focal, dorsal exophytic and cervicomedullary gliomas, are encountered less often and have a better prognosis. However, if untreated, they could also lead to progressive brainstem dysfunction and ultimately death.
2. Epidemiology
True incidence studies of brainstem gliomas are lacking. According to the Central Brain Tumor Registry of the United States, there were 400-450 cases of brainstem gliomas in children per year in the U.S. during 2004-2008, representing 10.7% of primary central nervous system tumors [7]. This number is higher than those previously estimated for the period between 1970s-1990s [8]. The increase is thought primarily to be a result of increased detection by the use of magnetic resonance imaging (MRI) and better data reporting as opposed to a true increase in the incidence of these tumors.
The most common age at diagnosis for DIPG is 5-9 years old with a median of 6.5 years, but cases have been seen in all age groups from infants to adults [5, 9]. Nondiffuse brainstem gliomas have roughly the same age distribution.
Neurofibromatosis type 1 (NF1) patients have higher incidence of brainstem gliomas. These tumors, whether diffuse or nondiffuse, appear to have a more benign course compared with tumors from patients without NF1 [10].
There does not appear to be a sex predilection in any of the brainstem tumor subgroups [5, 9]. Because of the low incidence and lack of diagnosis in less developed countries, there is not sufficient data to determine if there is a geographic propensity. No specific risk factors, either environmental or infectious, have been described to be related to the incidence of brainstem gliomas.
3. Classification
Brainstem gliomas are classified based on their location, focality and growth patterns. Classification systems were created using the current form of imaging available. Brainstem gliomas can be broadly categorized as diffuse intrinsic pontin glioma (DIPG) and nondiffuse brainstem gliomas. Nondiffuse brainstem gliomas can be further classified into three groups: focal gliomas (tectal and other locations), dorsal exophytic gliomas and cervicomedullary gliomas.
DIPG accounts for approximately 80% of brainstem gliomas in children [5, 6]. Surgical resection is not possible due to the location and infiltrative nature of the tumor. The standard of care for DIPG is radiation therapy. They have a median survival of about 10-12 months [6].
Focal gliomas account for about 5% of brainstem gliomas in children. They may be located anywhere within the brainstem but are typically not in the ventral pons. Most focal gliomas occur in the midbrain, especially the tectum of the midbrain. Focal gliomas in other areas of the brainstem, such as medulla, are less often seen. As a result, some discussions about focal gliomas may focus on tectal gliomas. Focal gliomas have well defined margins. They usually have an indolent course, and depending on location, are often amenable to surgical resection. The majority of tectal glioma patients have non-communicating hydrocephalus at initial presentation due to compression of cerebral aqueduct. Focal gliomas have a good prognosis [11].
Dorsal exophytic gliomas account for 10-15% of brainstem gliomas in children. They present insidiously with a long history of nonspecific headache and vomiting. They are amenable to surgical resection. These tumors have a good outcome after surgical resection [12].
Cervicomedullary gliomas account for 5-10% of brainstem gliomas in childrens. They arise from the lower medulla or the upper cervical spinal cord. They are amenable to surgical resection. Long-term tumor control can be achieved in most patients with surgical resection alone [13, 14].
4. Pathology and pathophysiology
Brainstem gliomas are typically astrocytomas. Focal, dorsal exophytic and cervicomedullary gliomas are usually pilocytic astrocytoma (WHO grade I) and fibrillary astrocytoma (WHO grade II). Other low-grade gliomas with indolent growth such as ganglioglioma are also seen. DIPGs are typically anaplastic astrocytoma (WHO grade III) and glioblastoma multiforme (WHO grade IV). Growth of low-grade gliomas typically respect fiber tracts and pial borders. In contrast, high-grade gliomas grow and expand without respecting anatomic boundaries of these surrounding tissues.
70-90% of DIPGs are anaplastic astrocytoma (WHO grade III) and glioblastoma multiforme (WHO grade IV) if biopsied before radiation therapy is given [15-17]. The remainders are mainly fibrillary astrocytoma (WHO grade II). At a later stage, invasion of adjacent levels of the brainstem and cerebellar peduncles is common. At autopsy, the vast majority of DIPGs are high-grade and more than 50% have disseminated within the neuraxis [18].
Most focal gliomas are low-grade [11, 19]. Low-grade gliomas seen in this subgroup include pilocytic astrocytoma, fibrillary astrocytoma and ganglioglioma. Most tectal gliomas cause hydrocephalus at an early stage due to its compression on the cerebral aqueduct.
Dorsal exophytic gliomas arise from subependymal glial tissue. Over 90% of these tumors are pilocytic astrocytomas [20] that grow along the path of least resistance. As a result, most of the tumor extends into the fourth ventricle rather than infiltrating the brainstem ventrally. Tumors that extend laterally and/or ventrally into the brainstem are usually more aggressive and of higher grade on pathological examination.
Cervicomedullary gliomas arise from either the lower medulla or upper cervical spinal cord. Most of them are low-grade astrocytomas, but gangliogliomas and ependymomas are also seen [14, 21]. Tumors with epicenters in the upper cervical cord grow dorsally into the cisterna magna. Those with epicenters in the lower medulla grow centrifugally as focal nodules.
5. Molecular genetics
Partially because of the low incidence of brainstem gliomas, their molecular genetics is less studied compared with some more common primary central nervous system tumors. However, there are some significant advances in the last a few years concerning both DIPG and focal brainstem gliomas.
DIPGs are genetically complex and distinct from both adult and pediatric supratentorial high-grade gliomas (HGG). Recent evidence points to platelet-derived growth factor (PDGF) and its receptors (PDGFR) as among the major driving forces of tumorigenesis in the majority of cases [22-26]. Another type of growth factor receptors involved in DIPG is epidermal growth factor receptor (EGFR). Expression of EGFR was reported in the majority of high grade and less than 20% of low grade DIPG by immunohistochemistry staining [27]. The same study also reported that 25% of grade III and 50% of grade IV tumors had EGFR gene amplification. Recent data show that strong EGFR immunohistochemistry staining was seen in about 27% cases [23], lower than in the earlier report, and that amplification rate of the EGFR gene is also much lower (about 7-9%) [23, 25]. Unlike the case in pediatric supratentorial HGG, CDKN2A deletion is non-existent in DIPG [25, 28] and amplification of CDK4 and CDK6 only occurs at a low rate [25]. Approximately 50% of DIPG had p53 mutation [29, 30] and three groups reported loss of a region of 17p containing the p53 gene in 31%, 57% and 64% cases, respectively [23, 28, 31]. In approximately 50% of DIPG patients, allelic loss of a region of 10q where PTEN is located was observed [31-33].
There have been fewer molecular genetics studies of nondiffuse brainstem gliomas. Recently it was reported that BRAF gene duplication and mutation are often observed in pediatric pilocytic astrocytomas and fibrillary astrocytomas, including those located in the brainstem [34-36].
6. Clinical presentation
The clinical behavior and presentation of brainstem gliomas are highly variable, depending on the anatomic location and growth pattern of the tumor, age of the patient and certain other factors. Symptom evolution reflects aggressiveness of the tumor. Low-grade tumors typically present with an insidious course over several months of gradual symptom progression. By comparison, a shorter and more abrupt onset of symptoms is indicative of higher-grade tumors.
Nondiffuse gliomas are often low-grade lesions with expectedly slow growth. Symptoms are insidious in onset and may not be readily appreciated. Careful history taking, including comparison to photographs, may be necessary to evaluate subtle changes associated with cranial nerve dysfunction in these slow-growing tumors. DIPGs, in comparison, typically present with a short prodrome of symptoms (usually 1-2 months or shorter) [9].
In brainstem gliomas, the pattern of symptoms reflects the extent of the tumor. Diffusely growing tumors are associated with multiple and bilateral cranial neuropathies, long tract signs and ataxia. Hydrocephalus in these tumors is uncommon at initial presentation. Nondiffuse gliomas often present with isolated cranial neuropathies, signs and symptoms of increased intracranial pressure, and ataxia. Rarely, hemiparesis may be part of the clinical presentation.
Brainstem glioma patients can have a combination of the following at presentation.
Cranial neuropathies are common in most tumors of the brainstem. Simultaneous involvement of multiple cranial nerves is more frequently encountered with diffuse lesions. Focal lesions, in contrast, are often associated with more limited cranial nerve involvement. Upper brainstem involvement is often associated with oculomotor deficits, and lesions of the lower brainstem are frequently found to have lower cranial nerve involvement resulting in changes in voice, dysphagia and/or aspiration pneumonias.
Long tract signs, including motor dysfunction and hyperreflexia, are most often associated with diffusely growing tumors or focal tumors of the cervicomedullary junction. Long tract signs are often conspicuously absent with dorsal exophytic gliomas [12].
In brainstem glioma patients, ataxia can be a result of loss of proprioceptive sensation, CN VIII involvement and/or invasion of cerebellar peduncles by the tumor. Ataxia is frequently seen in DIPG patients.
Obstructive hydrocephalus is usually the first sign seen in focal tectal gliomas as a result of the tumor compressing cerebral aqueduct. Hydrocephalus and its associated signs and symptoms are also often seen in dorsal exophytic gliomas which grow dorsally into the fourth ventricle resulting in the obstruction of normal cerebrospinal fluid (CSF) flow.
Failure to thrive is commonly encountered in infants with tumors of the cervicomedullary junction due to lower cranial nerve dysfunction resulting in swallowing difficulties.
6.1. Diffuse intrinsic pontine gliomas
DIPG patients usually have an acute onset and present with a history of rapid deterioration of 1-2 months or even shorter. Physical examination reveals classic brainstem signs: cranial nerve deficits, long tract signs and ataxia, or combinations of the three. At least two of the triad need to be present along with MRI evidence to establish the diagnosis of DIPG.
Bilateral and multiple cranial nerve involvement is frequent in DIPG. Abducens (CN VI) palsy is the most frequent cranial neuropathy at presentation [5]. Facial palsy is also frequently seen at initial presentation. Involvement of CN VIII causes deadness and contributes to ataxia. Lower cranial nerve involvement causes aspiration, and difficulty in speech, swallowing and maintaining normal head positions.
These children often present with severe limb weakness and hyperreflexia, resulting in their difficulty to walk and sometimes even to sit. Long tract involvement also causes loss of tactile, nociceptive and proprioceptive sensations, causing numbness and contributing to ataxia.
In DIPG patients, both CN VIII involvement and loss of proprioceptive sensation contribute to ataxia. Invasion of cerebellar peduncles is also common in DIPG, which is another factor contributing to ataxia.
DIPG patients may also have other symptoms including headache, nausea and vomiting etc. indicating increased intracranial pressure from edema or hydrocephalus. Approximately 10% of DIPG patients have hydrocephalus at initial presentation [5].
6.2. Focal gliomas
Focal gliomas can occur anywhere in the brainstem, but usually not in the vental pons. Their clinical presentations depend on the location.
Focal tectal gliomas have an insidious clinical course and often compress on cerebral aqueduct to cause a non-communicating hydrocephalus [11, 37]. As a result the initial presentation is usually those signs reflecting increased intracranial pressure: headache, vomiting, diplopia and papilledema.
Focal gliomas in the midbrain tegmentum and the medulla are usually larger than tectal gliomas and presents with cranial nerve dysfunction, long tract signs and ataxia [11, 38].
6.3. Dorsal exophytic gliomas
Dorsal exophytic gliomas grow into the fourth ventricle and typically present with signs and symptoms of increased intracranial pressure including headache, nausea and/or vomiting, lethargy, downward gaze preference, changes in vision and cranial nerve palsies (including abducens palsy). Infants with these tumors may present primarily with failure to thrive. Long tract signs are rare with these tumors [12].
6.4. Cervicomedullary gliomas
Cervicomedullary gliomas usually have an indolent course because the majority of these tumors are slow growing low-grade lesions. Two presenting syndromes have been described based on the epicenter of these tumors [39]. Medullary syndrome often presents as a failure to thrive secondary to nausea, vomiting or dysphagia. Also seen with this syndrome are sleep apnea, dysarthria and recurrent upper respiratory tract infections. Cervical cord syndrome presents with chronic neck pain and/or progressive myelopathy with spasticity and weakness. Hydrocephalus is unusual in cervicomedullary gliomas.
7. Imaging studies
Diagnosis of brainstem gliomas is based on clinical presentations and imaging studies. MRI is the imaging method of choice because of its high resolution and ability to differentiate the natures of lesions (tumor vs. inflammation etc.), which is especially important in the diagnosis of DIPG. MRI enables identification of important anatomic features and localization of tumors with multi-planar views. It allows a precise evaluation of the growth pattern and accurate preoperative diagnosis in most cases. Both T1- and T2-weighted axial and sagittal sequences should be obtained for the basic studies. Other useful sequences include fluid attenuated inversion recovery (FLAIR), diffusion tensor imaging (DTI), gradient echo (GRE) and susceptibility weighted imaging (SWI). DTI tractography may be useful in evaluating the relationship between the tumor and white matter tracts [40], which can be a part of the preoperative planning for nondiffuse brainstem gliomas.
7.1. Diffuse intrinsic pontine gliomas
DIPGs are diagnosed with clinical presentation and magnetic resonance imaging. Since the publication of the Children\'s Cancer Group (CCG) report in 1993 [41], when a brainstem tumor presents with typical symptoms and radiological appearance, it is usually considered that these findings are diagnostic and a biopsy is rarely performed. If, however, the clinical or radiological presentation is not typical, where brainstem encephalitis or an inflammatory process of the pons cannot be ruled out, a stereotactic biopsy would be needed before initiating radiation therapy and/or chemotherapy.
DIPGs infiltrate widely. MRI scans show infiltrative expansion of the pons that is typically hypointense on T1-weighted, hyperintense on T2-weighted and FLAIR images, and has no significant dorsal exophytic component. Involvement of adjacent levels of the brainstem and/or cerebellar peduncles is common. Envelopment of the basilar artery is commonly present in DIPG showing the tumor growing ventrally outside of the boundary of the brainstem. Contrast enhancement with gadolinium is variable, with no enhancement being common [42]. Enhancement, if present, is usually patchy, without known prognostic significance. Neuraxis dissemination of DIPG can be seen on MRI in more than 50% of patients during progression [18]. In some cases the tumor may show atypical features including prominent enhancement and/or hypointense T2-weighted/FLAIR signals.
Magnetic resonance spectroscopy (MRS) is helpful in differential diagnosis when the tumor shows atypical features. Increased Cho/NAA (choline/N-acetyl aspartate) and Cho/Cr (choline/creatine) ratios in DIPG are useful in differentiating it from brainstem encephalitis, demyelination and other inflammatory processes when clinical and MRI presentations are atypical [43, 44]. However, the differentiating power of MRS is limited in NF1-associated DIPG [43].
7.2. Focal gliomas
Before the availability of computed tomography (CT) and MRI for the diagnosis of intracranial lesions, focal tectal gliomas could only be found in autopsy evaluations. In the 1950s, when CSF diversion procedures were not as universally successful as of today, Kernohan and Sayre stated that tectal gliomas were “in all probability the smallest tumors in the human body that lead to the death of the patient [45].”
Focal gliomas show as focal lesions on MRI. Focal tectal gliomas are usually isointense on MRI and show as thickened tectal plate. Tectal gliomas rarely enhance with gadolinium [11, 37]. Central calcification may be noted rarely [46]. Hydrocephalus is seen in the vast majority of tectal gliomas, causing symptoms for which the patients are seeking medical attention.
Focal gliomas in other areas of the brainstem are usually hypointense on T1-weighted and hyperintense on T2-weighted images. The margins are well defined in focal tegmentum and medullary gliomas, and most are more or less round or spherical. They are frequently cystic with an intense rim enhancement after intravenous contrast agent administration. Most midbrain focal gliomas show upward extension to the thalamus and downward extension to the pons.
7.3. Dorsal exophytic gliomas
Dorsal exophytic gliomas typically erupt through the pia/ependyma early in their growth, so imaging will show that the bulk of tumor outside of the brainstem. Imaging of patients suspected of dorsal exophytic gliomas should include MRI studies with and without intravenous gadolinium of the brain to differentiate this type of tumor from tumors in the fourth ventricle such as primitive neuroectodermal tumors (PNETs). On MRI, dorsal exophytic gliomas appear as a dorsal exophytic expansion into the fourth ventricle or below the cerebellum. They usually show as sharply demarcated hypointense signals on T1-weighted and hyperintense on T2-weighted images. Bright homogeneous contrast enhancement and hydrocephalus are common MRI findings [20].
7.4. Cervicomedullary gliomas
Imaging of patients suspected cervicomedullary gliomas should include MRI studies with and without intravenous gadolinium of the brain and cervical spine to determine the extent of tumor growth and involvement.
Cervicomedullary gliomas arise from either the lower medulla or upper cervical spinal cord. Growth pattern of the tumor will give some hints as to their epicenters and what structures are being placed at risk by tumor growth. Tumors with epicenters in the upper cervical cord will have their rostral growth blocked by the decussating fibers of the sensory and motor pathways. Instead, the tumor curves dorsally to grow into the cisterna magna at the cervicomedullary junction. Tumors with epicenters in the lower medulla grow centrifugally as focal nodules pushing the surrounding fibers to their side [21].
Cervicomedullary gliomas appear as solid masses within the above-described areas. They are hypointense on T1-weighted and hyperintense on T2-weighted images. They typically enhance homogeneously upon gadolinium injection.
8. Diagnosis and differential diagnosis
Diagnosis of brainstem gliomas is based on clinical presentations and imaging studies and needs to address the location and nature of the lesion.
It is expected that the patient\'s clinical course, examination and imaging studies be in agreement. With nondiffuse brainstem gliomas this congruence often prompts surgical intervention (resection and/or relief of hydrocephalus), particularly for those located at the cervicomedullary junction or dorsal exophytic in growth.
Incongruence between presentation and clinical studies suggests the need for biopsy prior to definitive treatment. In cases with disagreement between the imaging findings and clinical course (i.e. rapidly progressive course with imaging consistent with a focal or low-grade lesion), frozen sections should be obtained at the time of surgery prior to progressing to an aggressive resection. These instances may be representative of a more malignant tumor in which case the potential for iatrogenic injury during resection outweighs the potential benefit of an extensive resection.
Differential diagnosis includes other tumors in the brainstem and adjacent regions and lesions of other natures. Other tumors include lymphoma, metastatic tumors, germinoma and nongerminomatous germ cell tumors, PNET, hemangioblastoma, lipoma, acoustic neuroma, etc. Some of these tumors typically arise from nearby regions and may encroach into the brainstem, e.g., primary intracranial germ cell tumors usually occur in the pineal region and can invade the brainstem. The majority of nongerminomatous germ cell tumors can be differentiated by testing for secreted markers in the blood such as α-fetoprotein and β-human chorionic growth hormone. PNET occurring in the brainstem, even though relatively rare, can appear similar to DIPG or nondiffuse brainstem gliomas. Because of the difference in treatment options from those for brainstem gliomas, it should be carefully differentiated when suspected. Lesions of other natures include infectious, autoimmune, other inflammatory, vascular and metabolic lesions etc.
The role of biopsy in the diagnosis of DIPG remains intensely debated [47, 48]. Before the wide adoption of MRI in the diagnosis of brainstem gliomas, biopsy was performed to confirm diagnosis and provide information on prognosis. However, biopsy has been only performed infrequently since mid-1990s. Of note is that since the Children\'s Cancer Group (CCG) report in 1993 [41], MRI has superseded biopsy as the main method of diagnosing DIPG. As better methods to characterize tumors become available and more molecularly targeted therapies have become available or are under development in recent years, there are increasing calls to perform biopsy more frequently in clinically diagnosed DIPGs. Brainstem biopsy is safe with low morbidity and mortality rates [49-51]. Survey showed that parents of children with DIPG are generally amenable to biopsy, even if the results may not benefit the patient [52]. Various focus groups have been holding discussions on criteria of recommending biopsy. Some investigational protocols of DIPG have included biopsy and molecular characterization as mandatory components in stratifying subjects for experimental therapy.
9. Treatment
Treatment of brainstem gliomas includes management of pain, bulbar symptoms and motor impairment, relief of hydrocephalus and general support. Brainstem glioma patients should be cared for by a multidisciplinary team including neurosurgeons, non-surgical specialists and other therapists.
Surgical intervention is indicated for certain nondiffuse brainstem gliomas. Tectal gliomas are usually indolent and present with hydrocephalus. Hydrocephalus is relieved by endoscopic third ventriculostomy (ETV) or ventricular shunt placement. Early resection of tectal gliomas is controversial. Dorsal exophytic gliomas are the most amenable to surgical resection in brainstem gliomas. The goal is to remove the exophytic component, and when safe, followed by debulking of the intrinsic component. Surgical resection is typically recommended early for cervicomedullary gliomas. Subtotal resection can be safely performed in most cases.
Adjuvant therapy for brainstem gliomas depends on the tumor location, pathological diagnosis and extent of previous surgical resection. Radiation therapy is the standard of care for DIPG, but it is not recommended as an early treatment for nondiffuse brainstem gliomas if pathology shows a low-grade glioma. It is usually used in patients with high-grade pathology, upon clinical and imaging evidence of progression, or late in the disease course [5, 38]. Stereotactic radiosurgery is also used in nondiffuse brainstem gliomas. Chemotherapy has limited use in the management of brainstem gliomas. It is mainly used for high-grade pathology or at late stage of the disease.
9.1. Diffuse intrinsic pontine glioma
Surgical resection of DIPG is not safe because of its location and infiltrative nature. Biopsy is not indicated for patients with typical clinical presentation and MRI findings. Hydrocephalus, if present, should be treated with either an ETV or a shunt. A histological confirmation might be needed if imaging or clinical history is not typical for a DIPG, or if an investigational protocol requests it.
The standard of care for DIPG is involved field external beam radiation therapy, typically delivered at 1.8Gy/fraction for 30-33 fractions in the North America. Significant clinical improvement occurs in 85% of patients receiving radiation therapy, but the improvement is usually transient, lasting only 3-4 months, before progressive decline in clinical status returns [6].
Various chemotherapeutic regimens have been studied either alone or in combination with radiation therapy. However, up to date, no chemotherapeutic agent, either alone or in combination, or in conjunction with radiation therapy, has altered the natural history of DIPG. Many patients are enrolled in clinical trials of new agents or previously used agents in previously untested combinations.
9.2. Focal gliomas
Most tectal gliomas in children have indolent growth with few symptoms except those caused by hydrocephalus. Early resection of focal tectal gliomas is controversial and infrequently done. Often, these tumors are managed by relief of hydrocephalus, followed by clinical observation and periodic MRI scans [53, 54]. Treatment of the hydrocephalus typically includes ETV to restore CSF flow. Shunting is an alternative or can be considered for patients who fail ETV. Surgical resection may be considered on rare occasions.
Focal gliomas in other areas of the brainstem, including tegmentum and medulla, are usually indicated for surgical resection. Tissue diagnosis before radical resection is indicated for lesions with atypical clinical and imaging findings. For those patients initially put on observation, when tumor progression is observed, biopsy or sometimes radical resection is indicated. Transventricular endoscopic biopsy may be performed with or without CSF diversion when the tumor is adjacent to a ventricle’s walls [55]. Stereotactic biopsies may be considered for lesions that cannot be approached with endoscopy where accurate histological diagnosis is warranted but more aggressive surgical resection is deemed unsafe. Surgical resection of focal, well-circumscribed lesions provides not only a tissue diagnosis but also a prolonged event-free survival in many cases.
Conventional radiation therapy has demonstrated limited efficacy in patients with focal gliomas. Tumors with high-grade features should be treated with radiation therapy after recovery from surgery or when surgery is not indicated, while low-grade tumors may be observed and treated only if there is subsequent tumor progression [5, 38]. Implantation of iodine-129 (I-129) or iodine-125 (I-125) seeds has been used in some patients with acceptable tumor control. I-125 is an alternative to resection, external beam radiation therapy and chemotherapy in children with progressively symptomatic low-grade gliomas in deep and eloquent areas where high postoperative morbidity would be expected with open surgery [56]. Stereotactic radiosurgery has been used as an alternative means for managing focal brainstem gliomas [57]. Its use has been reported in patients with progressive tumor growth or worsening neurological deficits.
The role of chemotherapy has not been well evaluated for focal brainstem gliomas. In general, for tumors that total or subtotal resection has been performed on and subsequently progress, chemotherapy may be considered with or without radiation therapy. In children younger than 3 years old, chemotherapy may be used alone in attempts to delay the need for radiation therapy.
9.3. Dorsal exophytic gliomas
Dorsal exophytic gliomas are the group most amenable to surgical resection among brainstem gliomas and total or near total resection alone usually results in a good prognosis [12, 20]. Long-term event-free survival is expected when these tumors are simply shaven down to the level of the floor of the fourth ventricle. They should not be aggressively "chased" into the brainstem. In patients with findings consistent with an obstructive hydrocephalus who have not previously undergone a CSF diversion procedure (e.g. ETV or shunting), placement of an external ventricular drain may be considered. Tumor specimens should be sent early for frozen sections. A high-grade lesion is an indication to halt the surgery, as there is no proven long-term benefit to debulking aggressive lesions. Resection of the tumor takes place primarily within the fourth ventricle on the extra-axial part. In instances where there is a large intramedullary component to the tumor or if it is felt that damage to the functional tissues of the brainstem would be unavoidable, subtotal resection should be attempted. Some have advocated that resection carried to the level of the floor of the fourth ventricle confers a sufficient balance between disease control and preservation of neurological function by minimizing the risk of injuring functional brainstem tissues.
Radiation therapy is used for inoperable tumors or recurrent disease not amenable to re-resection [5, 38]. Treatment primarily consists of conventional external beam radiation therapy with 30-33 daily fractions of 1.8Gy/fraction [58-60]. The use of stereotactic radiation therapy and radiosurgery has also been examined in small cohorts. Chemotherapy has no proven efficacy in the treatment of dorsal exophytic gliomas [61].
9.4. Cervicomedullary gliomas
Cervicomedullary gliomas are treated in a fashion similar to that of an intramedullary spinal cord glioma or a focal glioma of the medulla depending on the location of the epicenter. Specimens should be sent early for frozen sections. Identification of a high-grade lesion is an indication to halt the surgery, as there is no proven long-term benefit to debulking aggressive lesions. Surgical resection should begin with internal debulking from the center to periphery.
As the majority of these tumors are low grade, surgery is typically the initial treatment modality. Radiation therapy should be reserved for advanced or recurrent diseases not amenable to surgical resection [5, 38]. Treatment primarily consists of conventional fractionated external beam radiation given at 1.8Gy/fraction for 30-33 fractions [58-60]. The use of stereotactic radiation therapy and radiosurgery has also been examined in small cohorts. Although a number of trials have examined the efficacy of chemotherapy in the treatment of DIPG, no role has been defined for its use in the treatment of cervicomedullary tumors [61].
10. Outcomes
The outcome of brainstem gliomas depends on the location and pathological grade of the tumor. Focal, dorsal exophytic and cervicomedullary gliomas typically have a fairly good prognosis. In contrast, the median survival of DIPG patients is only about one year despite numerous investigational therapies. In both DIPG and nondiffuse brainstem gliomas, patients with neurofibromatosis, older age, and longer duration of symptoms before diagnosis are thought to have a more favorable outcome [10].
10.1. Diffuse intrinsic pontine gliomas
External beam radiation therapy transiently improves the neurological condition in 85% of DIPG patients, but the disease usually progresses within 3-4 months. No treatment has been shown to be effective at the time of progression. Clinical deterioration is usually fast once progression is detected. Median survival is 10-12 months. Only 10% of patients survive beyond two years after diagnosis [6]. Children under the age of 3 years, young adults over 18 and those with NF1 may have a better prognosis.
10.2. Focal gliomas
Lesions typical of tectal gliomas on imaging studies usually need treatment for hydrocephalus only and rarely progress over many years. Hydrocephalus can be well managed in tectal gliomas. ETV for tectal gliomas has a success rate exceeding 70% and as high as 90%. Focal gliomas in other areas of the brainstem, especially if the pathology is pilocytic astrosytoma, can be cured by gross total resection but long-term follow-up is necessary. One study noted a 4-year progression-free survival rate of 94% and an overall 4-year survival rate of 100% in 17 patients with focal midbrain gliomas, which included tectal gliomas [11]. Stereotactic radiosurgery may be an effective primary treatment or adjunct to open surgery for focal brainstem gliomas. After gamma knife radiosurgery, most patients improved or stabilized but some worsened [57].
10.3. Dorsal exophytic gliomas
Dorsal exophytic gliomas are amenable to surgical resection. Gross total or subtotal resection can be achieved in most cases. They have a good outcome after surgical resection. Among 18 patients who underwent surgery, 17 survived and only four showed evidence of radiological progression after a median follow-up of 113 months [12]. Subsequent progression may require re-resection or radiation therapy.
10.4. Cervicomedullary gliomas
Tumor control can be achieved by surgical resection in most patients with cervicomedullary gliomas. 5-year progression-free survival rate is 60% and overall 5-year survival rate about 90% after surgical resection alone [14].
11. Recent advances and future directions
Because of the dismal prognosis of DIPG and the lack of therapeutic efficacy of current chemotherapies, innovative approach is urgently needed for the disease. One promising drug delivery method that may improve the outcome of DIPG patients is convection-enhanced delivery (CED). Another recent advance is the molecular characterization of DIPG, which may provide guidance for developing new therapies.
11.1. Convection-enhanced delivery
The blood-brain barrier (BBB) presents a significant obstacle to achieving therapeutic concentrations of systemically delivered agents in brain tumors. Convection-enhanced delivery (CED) is a method of local delivery that bypasses the BBB [62]. CED is typically accomplished by inserting a small-bore cannula directly into a tumor followed by drug infusion through the cannula. Experimental studies have led to the recognition that CED can be characterized by several common features:
Local drug concentration can exceed that achieved with systemic administration by several thousand times.
Systemic exposure by efflux into the vasculature is minimal.
Tissue penetration by CED is well beyond that achieved by other local delivery methods that rely on diffusion rather than bulk flow such as drug-impregnated polymers.
Distribution is preferentially along white matter tracts, a pattern reminiscent of glioma cell invasion.
CED can be used to deliver macromolecules such as monoclonal antibodies or recombinant toxins, which is not possible by systemic administration in the brain parenchyma or tumor.
It is hypothesized that CED is ideally suited for the treatment of DIPG based on several features particular to this disease such as the tumor’s relative compact growth pattern, its tendency to migrate along white matter fibers, the rarity of tumor related cysts and the lack of cavitary changes from radiation therapy.
The safety of CED in the brainstem has been well established in rodents and non-human primates [63-71]. The tolerability of several therapeutic agents delivered using CED into the brainstem has also been investigated and most of them proven to be safe at high concentrations [72-78]. This approach has been safely used on a limited clinical basis.
Although it is clear that certain limitations exist in the application of CED for the treatment of DIPG, currently existing preclinical data are sufficient to guide the design of clinical studies. Decisions in the design of these studies include the selection of an appropriate agent or agents, surgical technique, parameters of infusion, timing of treatment and methods of assessing distribution, local concentration, safety and therapeutic efficacy. These questions, however, should not be a barrier for clinical implementation, but rather as goals for early phase clinical studies. Based on current preclinical data, CED may serve as the basis for a new approach in the treatment of DIPG.
11.2. Molecular characterization of diffuse intrinsic pontine gliomas
A promising advance that may aid the development of therapeutic agents for the treatment of DIPG is the recent molecular characterization of this tumor. Four groups independently discovered that platelet-derived growth factor (PDGF) and its receptors (PDGFR) are amplified or over-expressed in the majority of these tumors [22-26]. Another type of growth factor receptors involved in DIPG is epidermal growth factor receptor (EGFR). Expression of EGFR was reported in the majority of high grade and less than 20% of low grade DIPG by immunohistochemistry staining [27]. The same study also reported that 25% of grade III and 50% of grade IV tumors had EGFR gene amplification. Recent data show that strong EGFR immunohistochemistry staining was seen in about 27% cases [23], lower than in the earlier report, and that amplification rate of the EGFR gene is also much lower (about 7-9%) [23, 25]. Unlike the case in pediatric supratentorial HGG, CDKN2A deletion is non-existent in DIPG [25, 28] and amplification of CDK4 and CDK6 only occurs at a low rate [25]. Approximately 50% of DIPG had p53 mutation [29, 30] and three groups reported loss of a region of 17p containing the p53 gene in 31%, 57% and 64% cases, respectively [23, 28, 31]. In approximately 50% of DIPG patients, allelic loss of a region of 10q where PTEN is located was observed [31-33]. Like in adult malignant gliomas, the interleukin-13 receptor subtype IL-13Rα2 is highly expressed in DIPG [79].
Some of these genetic aberrations have been the basis for DIPG animal models that could be powerful tools for studying the disease, e.g., Becher et al. designed a mouse model of DIPG based on PDGF overexpression [22]. Some of the molecular abnormalities have already been used as therapeutic targets. There are therapeutic monoclonal antibodies targeting PDGFR, namely IMC-3G3 (ImClone) and MEDI-575 (MedImmune), that need to be tested for efficacy in treating DIPG, preferably delivered through CED into the tumor since they are macromolecules unable to cross the BBB. There are numerous small molecule tyrosine kinase inhibitors with strong inhibitory effects on PDGFR and/or EGFR kinases, and inhibitors of downstream signaling molecules such as AKT and mTOR, that are undergoing clinical trials for the treatment of DIPG. There are also targeted recombinant toxins, e.g. IL13-PE38QQR, utilizing IL-13 as the targeting moiety to target tumor cells overexpressing IL-13 receptors. Even though biopsy of DIPG is far from being routine, when these molecularly targeted therapies come to clinical use, it would be ideal for the tumor to be pre-screened for specific targets of those agents.
12. Conclusion
Brainstem gliomas are a heterogeneous group of neoplasms with considerably diverse natural histories and prognoses. They are classified into four groups based on their location, focality and growth patterns. Diffuse intrinsic pontine gliomas (DIPG) account for approximately 80% of brainstem gliomas. The overwhelming majority of them is high grade. They are not resectable and the standard of care is involved field external beam radiation therapy. They have a dismal prognosis. The vast majority of focal, dorsal exophytic and cervicomedullary gliomas is low grade, often amenable to surgical resection and has a more favorable outcome.
Developing effective therapy for DIPG is so far frustrating as neither new schedules of radiation therapy nor chemotherapeutic regimens being studied have improved survival of these patients. As better molecular characterization methods become available, there are increasing calls to perform biopsy and tissue diagnosis in clinically diagnosed DIPGs. Recent molecular characterization of DIPG identified some genetic aberrations that could be used as effective therapeutic targets, including PDGF and PDGF receptors. There are both large and small molecule agents targeting these genetic aberrations that are either available or under development. However, most of these agents are unable to cross the blood-brain barrier (BBB) to reach the tumor. Convection-enhanced delivery (CED) is a drug delivery method to bypass the BBB. It has proven capability to deliver high local drug concentrations and the safety of its use in the brainstem has been established in small and large animals and a small number of patients. CED, combined with conventional chemotherapeutic drugs and novel targeted agents, has the potential to produce an effective treatment for DIPG.
\n',keywords:null,chapterPDFUrl:"https://cdn.intechopen.com/pdfs/43962.pdf",chapterXML:"https://mts.intechopen.com/source/xml/43962.xml",downloadPdfUrl:"/chapter/pdf-download/43962",previewPdfUrl:"/chapter/pdf-preview/43962",totalDownloads:3033,totalViews:284,totalCrossrefCites:0,totalDimensionsCites:0,totalAltmetricsMentions:0,impactScore:0,impactScorePercentile:12,impactScoreQuartile:1,hasAltmetrics:0,dateSubmitted:"May 5th 2012",dateReviewed:"September 28th 2012",datePrePublished:null,datePublished:"April 10th 2013",dateFinished:"March 28th 2013",readingETA:"0",abstract:null,reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/43962",risUrl:"/chapter/ris/43962",book:{id:"3277",slug:"clinical-management-and-evolving-novel-therapeutic-strategies-for-patients-with-brain-tumors"},signatures:"Zhiping Zhou and Mark M. Souweidane",authors:[{id:"45389",title:"Dr.",name:"Mark",middleName:"M.",surname:"Souweidane",fullName:"Mark Souweidane",slug:"mark-souweidane",email:"mmsouwei@med.cornell.edu",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null},{id:"158907",title:"Dr.",name:"Zhiping",middleName:null,surname:"Zhou",fullName:"Zhiping Zhou",slug:"zhiping-zhou",email:"zhz2004@med.cornell.edu",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Epidemiology",level:"1"},{id:"sec_3",title:"3. Classification",level:"1"},{id:"sec_4",title:"4. Pathology and pathophysiology",level:"1"},{id:"sec_5",title:"5. Molecular genetics",level:"1"},{id:"sec_6",title:"6. Clinical presentation",level:"1"},{id:"sec_6_2",title:"6.1. Diffuse intrinsic pontine gliomas",level:"2"},{id:"sec_7_2",title:"6.2. Focal gliomas",level:"2"},{id:"sec_8_2",title:"6.3. Dorsal exophytic gliomas",level:"2"},{id:"sec_9_2",title:"6.4. Cervicomedullary gliomas",level:"2"},{id:"sec_11",title:"7. Imaging studies",level:"1"},{id:"sec_11_2",title:"7.1. Diffuse intrinsic pontine gliomas",level:"2"},{id:"sec_12_2",title:"7.2. Focal gliomas",level:"2"},{id:"sec_13_2",title:"7.3. Dorsal exophytic gliomas",level:"2"},{id:"sec_14_2",title:"7.4. Cervicomedullary gliomas",level:"2"},{id:"sec_16",title:"8. Diagnosis and differential diagnosis",level:"1"},{id:"sec_17",title:"9. Treatment",level:"1"},{id:"sec_17_2",title:"9.1. Diffuse intrinsic pontine glioma",level:"2"},{id:"sec_18_2",title:"9.2. Focal gliomas",level:"2"},{id:"sec_19_2",title:"9.3. Dorsal exophytic gliomas",level:"2"},{id:"sec_20_2",title:"9.4. Cervicomedullary gliomas",level:"2"},{id:"sec_22",title:"10. Outcomes",level:"1"},{id:"sec_22_2",title:"10.1. Diffuse intrinsic pontine gliomas",level:"2"},{id:"sec_23_2",title:"10.2. Focal gliomas",level:"2"},{id:"sec_24_2",title:"10.3. Dorsal exophytic gliomas",level:"2"},{id:"sec_25_2",title:"10.4. Cervicomedullary gliomas",level:"2"},{id:"sec_27",title:"11. Recent advances and future directions",level:"1"},{id:"sec_27_2",title:"11.1. Convection-enhanced delivery",level:"2"},{id:"sec_28_2",title:"11.2. Molecular characterization of diffuse intrinsic pontine gliomas",level:"2"},{id:"sec_30",title:"12. Conclusion",level:"1"}],chapterReferences:[{id:"B1",body:'[Panitch, H.S. and B.O. Berg, Brain stem tumors of childhood and adolescence. Am J Dis Child, 1970. 119(6): p. 465-72.]'},{id:"B2",body:'[Farwell, J.R., G.J. Dohrmann, and J.T. Flannery, Central nervous system tumors in children. Cancer, 1977. 40(6): p. 3123-32.]'},{id:"B3",body:'[Albright, A.L., R.A. Price, and A.N. Guthkelch, Brain stem gliomas of children. A clinicopathological study. Cancer, 1983. 52(12): p. 2313-9.]'},{id:"B4",body:'[Pierre-Kahn, A., et al., Surgical management of brain-stem tumors in children: results and statistical analysis of 75 cases. J Neurosurg, 1993. 79(6): p. 845-52.]'},{id:"B5",body:'[Freeman, C.R. and J.P. Farmer, Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys, 1998. 40(2): p. 265-71.]'},{id:"B6",body:'[Hargrave, D., U. Bartels, and E. Bouffet, Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol, 2006. 7(3): p. 241-8.]'},{id:"B7",body:'[Central Brain Tumor Registry of the United States, CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2008. 2012.]'},{id:"B8",body:'[Smith, M.A., et al., Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst, 1998. 90(17): p. 1269-77.]'},{id:"B9",body:'[Kaplan, A.M., et al., Brainstem gliomas in children. A Children\'s Cancer Group review of 119 cases. Pediatr Neurosurg, 1996. 24(4): p. 185-92.]'},{id:"B10",body:'[Ullrich, N.J., et al., Brainstem lesions in neurofibromatosis type 1. Neurosurgery, 2007. 61(4): p. 762-6; discussion 766-7.]'},{id:"B11",body:'[Robertson, P.L., et al., Pediatric midbrain tumors: a benign subgroup of brainstem gliomas. Pediatr Neurosurg, 1995. 22(2): p. 65-73.]'},{id:"B12",body:'[Pollack, I.F., et al., The long-term outcome after surgical treatment of dorsally exophytic brain-stem gliomas. J Neurosurg, 1993. 78(6): p. 859-63.]'},{id:"B13",body:'[Young Poussaint, T., et al., Cervicomedullary astrocytomas of childhood: clinical and imaging follow-up. Pediatr Radiol, 1999. 29(9): p. 662-8.]'},{id:"B14",body:'[Weiner, H.L., et al., Intra-axial tumors of the cervicomedullary junction: surgical results and long-term outcome. Pediatr Neurosurg, 1997. 27(1): p. 12-8.]'},{id:"B15",body:'[Wolff, J.E., et al., Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database. J Neurooncol, 2008. 87(2): p. 155-64.]'},{id:"B16",body:'[Wolff, J.E., et al., Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol. Cancer, 2010. 116(3): p. 705-12.]'},{id:"B17",body:'[Cartmill, M. and J. Punt, Diffuse brain stem glioma. A review of stereotactic biopsies. Childs Nerv Syst, 1999. 15(5): p. 235-7; discussion 238.]'},{id:"B18",body:'[Sethi, R., et al., Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma. J Neurooncol, 2011. 102(1): p. 121-7.]'},{id:"B19",body:'[Hoffman, H.J., L. Becker, and M.A. Craven, A clinically and pathologically distinct group of benign brain stem gliomas. Neurosurgery, 1980. 7(3): p. 243-8.]'},{id:"B20",body:'[Khatib, Z.A., et al., Predominance of pilocytic histology in dorsally exophytic brain stem tumors. Pediatr Neurosurg, 1994. 20(1): p. 2-10.]'},{id:"B21",body:'[Epstein, F.J. and J.P. Farmer, Brain-stem glioma growth patterns. J Neurosurg, 1993. 78(3): p. 408-12.]'},{id:"B22",body:'[Becher, O.J., et al., Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma. Cancer Res, 2010. 70(6): p. 2548-57.]'},{id:"B23",body:'[Zarghooni, M., et al., Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol, 2010. 28(8): p. 1337-44.]'},{id:"B24",body:'[Puget, S., et al., Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One, 2012. 7(2): p. e30313.]'},{id:"B25",body:'[Paugh, B.S., et al., Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol, 2011. 29(30): p. 3999-4006.]'},{id:"B26",body:'[Paugh, B.S., et al., Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol, 2010. 28(18): p. 3061-8.]'},{id:"B27",body:'[Gilbertson, R.J., et al., ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res, 2003. 9(10 Pt 1): p. 3620-4.]'},{id:"B28",body:'[Barrow, J., et al., Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas. Neuro Oncol, 2011. 13(2): p. 212-22.]'},{id:"B29",body:'[Badhe, P.B., P.P. Chauhan, and N.K. Mehta, Brainstem gliomas--a clinicopathological study of 45 cases with p53 immunohistochemistry. Indian J Cancer, 2004. 41(4): p. 170-4.]'},{id:"B30",body:'[Zhang, S., et al., p53 gene mutations in pontine gliomas of juvenile onset. Biochem Biophys Res Commun, 1993. 196(2): p. 851-7.]'},{id:"B31",body:'[Louis, D.N., et al., Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens. J Neuropathol Exp Neurol, 1993. 52(5): p. 507-15.]'},{id:"B32",body:'[Cheng, Y. and H. Wu, [Recent advances on molecular biology of diffuse astrocytoma]. Zhonghua Bing Li Xue Za Zhi, 1999. 28(3): p. 165-8.]'},{id:"B33",body:'[Cheng, Y., et al., Genetic alterations in pediatric high-grade astrocytomas. Hum Pathol, 1999. 30(11): p. 1284-90.]'},{id:"B34",body:'[Pfister, S., et al., BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest, 2008. 118(5): p. 1739-49.]'},{id:"B35",body:'[Schindler, G., et al., Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol, 2011. 121(3): p. 397-405.]'},{id:"B36",body:'[Horbinski, C., et al., Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas. Acta Neuropathol, 2010. 119(5): p. 641-9.]'},{id:"B37",body:'[Bowers, D.C., et al., Tectal gliomas: natural history of an indolent lesion in pediatric patients. Pediatr Neurosurg, 2000. 32(1): p. 24-9.]'},{id:"B38",body:'[Ueoka, D.I., et al., Brainstem gliomas--retrospective analysis of 86 patients. J Neurol Sci, 2009. 281(1-2): p. 20-3.]'},{id:"B39",body:'[Epstein, F. and J. Wisoff, Intra-axial tumors of the cervicomedullary junction. J Neurosurg, 1987. 67(4): p. 483-7.]'},{id:"B40",body:'[Helton, K.J., et al., Diffusion tensor imaging of brainstem tumors: axonal degeneration of motor and sensory tracts. J Neurosurg Pediatr, 2008. 1(4): p. 270-6.]'},{id:"B41",body:'[Albright, A.L., et al., Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children\'s Cancer Group. Neurosurgery, 1993. 33(6): p. 1026-9; discussion 1029-30.]'},{id:"B42",body:'[Mauffrey, C., Paediatric brainstem gliomas: prognostic factors and management. J Clin Neurosci, 2006. 13(4): p. 431-7.]'},{id:"B43",body:'[Porto, L., et al., Proton magnetic resonance spectroscopy in childhood brainstem lesions. Childs Nerv Syst, 2007. 23(3): p. 305-14.]'},{id:"B44",body:'[Thakur, S.B., et al., Longitudinal MR spectroscopic imaging of pediatric diffuse pontine tumors to assess tumor aggression and progression. AJNR Am J Neuroradiol, 2006. 27(4): p. 806-9.]'},{id:"B45",body:'[Kernohan, G.W. and G.S. Sayre, Tumors of the central nervous system, in Atlas of Tumor Pathology: Section X1952, Armed Forces Institute of Pathology: Washington, DC.]'},{id:"B46",body:'[Daglioglu, E., O. Cataltepe, and N. Akalan, Tectal gliomas in children: the implications for natural history and management strategy. Pediatr Neurosurg, 2003. 38(5): p. 223-31.]'},{id:"B47",body:'[Leach, P.A., et al., Diffuse brainstem gliomas in children: should we or shouldn\'t we biopsy? Br J Neurosurg, 2008. 22(5): p. 619-24.]'},{id:"B48",body:'[Wilkinson, R. and J. Harris, Moral and legal reasons for altruism in the case of brainstem biopsy in diffuse glioma. Br J Neurosurg, 2008. 22(5): p. 617-8.]'},{id:"B49",body:'[Pincus, D.W., et al., Brainstem stereotactic biopsy sampling in children. J Neurosurg, 2006. 104(2 Suppl): p. 108-14.]'},{id:"B50",body:'[Pirotte, B.J., et al., Results of positron emission tomography guidance and reassessment of the utility of and indications for stereotactic biopsy in children with infiltrative brainstem tumors. J Neurosurg, 2007. 107(5 Suppl): p. 392-9.]'},{id:"B51",body:'[Roujeau, T., et al., Stereotactic biopsy of diffuse pontine lesions in children. J Neurosurg, 2007. 107(1 Suppl): p. 1-4.]'},{id:"B52",body:'[Bartels, U., et al., Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG. J Neurooncol, 2011. 105(1): p. 119-25.]'},{id:"B53",body:'[Walker, D.A., J.A. Punt, and M. Sokal, Clinical management of brain stem glioma. Arch Dis Child, 1999. 80(6): p. 558-64.]'},{id:"B54",body:'[Sandri, A., et al., Diffuse and focal brain stem tumors in childhood: prognostic factors and surgical outcome. Experience in a single institution. Childs Nerv Syst, 2006. 22(9): p. 1127-35.]'},{id:"B55",body:'[Ahn, E.S. and L. Goumnerova, Endoscopic biopsy of brain tumors in children: diagnostic success and utility in guiding treatment strategies. J Neurosurg Pediatr, 2010. 5(3): p. 255-62.]'},{id:"B56",body:'[Korinthenberg, R., et al., Long-term results of brachytherapy with temporary iodine-125 seeds in children with low-grade gliomas. Int J Radiat Oncol Biol Phys, 2011. 79(4): p. 1131-8.]'},{id:"B57",body:'[Yen, C.P., et al., Gamma knife surgery for focal brainstem gliomas. J Neurosurg, 2007. 106(1): p. 8-17.]'},{id:"B58",body:'[Schild, S.E., et al., The results of radiotherapy for brainstem tumors. J Neurooncol, 1998. 40(2): p. 171-7.]'},{id:"B59",body:'[Skowronska-Gardas, A., Evaluation of radiotherapy for pediatric CNS tumors. Expert Rev Neurother, 2003. 3(4): p. 491-500.]'},{id:"B60",body:'[Hoffman, K.E. and T.I. Yock, Radiation therapy for pediatric central nervous system tumors. J Child Neurol, 2009. 24(11): p. 1387-96.]'},{id:"B61",body:'[Allen, J.C. and J. Siffert, Contemporary chemotherapy issues for children with brainstem gliomas. Pediatr Neurosurg, 1996. 24(2): p. 98-102.]'},{id:"B62",body:'[Bobo, R.H., et al., Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A, 1994. 91(6): p. 2076-80.]'},{id:"B63",body:'[Sandberg, D.I., M.A. Edgar, and M.M. Souweidane, Effect of hyperosmolar mannitol on convection-enhanced delivery into the rat brain stem. J Neurooncol, 2002. 58(3): p. 187-92.]'},{id:"B64",body:'[Sandberg, D.I., M.A. Edgar, and M.M. Souweidane, Convection-enhanced delivery into the rat brainstem. J Neurosurg, 2002. 96(5): p. 885-91.]'},{id:"B65",body:'[Occhiogrosso, G., et al., Prolonged convection-enhanced delivery into the rat brainstem. Neurosurgery, 2003. 52(2): p. 388-93; discussion 393-4.]'},{id:"B66",body:'[Croteau, D., et al., Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracer. J Neurosurg, 2005. 102(1): p. 90-7.]'},{id:"B67",body:'[Krauze, M.T., et al., Safety of real-time convection-enhanced delivery of liposomes to primate brain: a long-term retrospective. Exp Neurol, 2008. 210(2): p. 638-44.]'},{id:"B68",body:'[Laske, D.W., et al., Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging. J Neurosurg, 1997. 87(4): p. 586-94.]'},{id:"B69",body:'[Lonser, R.R., et al., Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease. Neurology, 2007. 68(4): p. 254-61.]'},{id:"B70",body:'[Lonser, R.R., et al., Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. J Neurosurg, 2002. 97(4): p. 905-13.]'},{id:"B71",body:'[Nguyen, T.T., et al., Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. J Neurosurg, 2003. 98(3): p. 584-90.]'},{id:"B72",body:'[Souweidane, M.M., et al., Interstitial infusion of IL13-PE38QQR in the rat brain stem. J Neurooncol, 2004. 67(3): p. 287-93.]'},{id:"B73",body:'[Souweidane, M.M., et al., Interstitial infusion of carmustine in the rat brain stem with systemic administration of O6-benzylguanine. J Neurooncol, 2004. 67(3): p. 319-26.]'},{id:"B74",body:'[Luther, N., et al., Intraparenchymal and intratumoral interstitial infusion of anti-glioma monoclonal antibody 8H9. Neurosurgery, 2008. 63(6): p. 1166-74; discussion 1174.]'},{id:"B75",body:'[Luther, N., et al., Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38. Mol Cancer Ther, 2010. 9(4): p. 1039-46.]'},{id:"B76",body:'[Murad, G.J., et al., Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to pseudomonas exotoxin. Clin Cancer Res, 2006. 12(10): p. 3145-51.]'},{id:"B77",body:'[Murad, G.J., et al., Image-guided convection-enhanced delivery of gemcitabine to the brainstem. J Neurosurg, 2007. 106(2): p. 351-6.]'},{id:"B78",body:'[Szerlip, N.J., et al., Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles. J Neurosurg, 2007. 107(3): p. 560-7.]'},{id:"B79",body:'[Joshi, B.H., et al., Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma. Neuro Oncol, 2008. 10(3): p. 265-74.]'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Zhiping Zhou",address:"zhz2004@med.cornell.edu",affiliation:'- Department of Neurological Surgery, Weill Medical College of Cornell University, New York, NY, USA
'},{corresp:null,contributorFullName:"Mark M. Souweidane",address:null,affiliation:'- Department of Neurological Surgery, Weill Medical College of Cornell University, New York, NY, USA
- Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
'}],corrections:null},book:{id:"3277",type:"book",title:"Clinical Management and Evolving Novel Therapeutic Strategies for Patients with Brain Tumors",subtitle:null,fullTitle:"Clinical Management and Evolving Novel Therapeutic Strategies for Patients with Brain Tumors",slug:"clinical-management-and-evolving-novel-therapeutic-strategies-for-patients-with-brain-tumors",publishedDate:"April 10th 2013",bookSignature:"Terry Lichtor",coverURL:"https://cdn.intechopen.com/books/images_new/3277.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:null,printIsbn:"978-953-51-1058-3",pdfIsbn:"978-953-51-7123-2",reviewType:"peer-reviewed",numberOfWosCitations:32,isAvailableForWebshopOrdering:!0,editors:[{id:"37886",title:"Dr.",name:"Terry",middleName:null,surname:"Lichtor",slug:"terry-lichtor",fullName:"Terry Lichtor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1085"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"40951",type:"chapter",title:"Navigated Brain Stimulation (NBS) for Pre-Surgical Planning of Brain Lesion in Critical Areas: Basic Principles and Early Experience",slug:"navigated-brain-stimulation-nbs-for-pre-surgical-planning-of-brain-lesion-in-critical-areas-basic-pr",totalDownloads:2115,totalCrossrefCites:0,signatures:"Concetta Alafaci, Alfredo Conti and Francesco Tomasello",reviewType:"peer-reviewed",authors:[{id:"54268",title:"Prof.",name:"Concetta",middleName:null,surname:"Alafaci",fullName:"Concetta Alafaci",slug:"concetta-alafaci"},{id:"159275",title:"Dr.",name:"Alfredo",middleName:null,surname:"Conti",fullName:"Alfredo Conti",slug:"alfredo-conti"},{id:"159276",title:"Prof.",name:"Francesco",middleName:null,surname:"Tomasello",fullName:"Francesco Tomasello",slug:"francesco-tomasello"}]},{id:"43881",type:"chapter",title:"Functional MRI, Diffusion Tensor Imaging, Magnetic Source Imaging and Intraoperative Neuromonitoring Guided Brain Tumor Resection in Awake and Under General Anaesthesia",slug:"functional-mri-diffusion-tensor-imaging-magnetic-source-imaging-and-intraoperative-neuromonitoring-g",totalDownloads:2524,totalCrossrefCites:3,signatures:"Zamzuri Idris, W M Nazaruddin W Hassan, Muzaimi Mustapha, Badrisyah Idris, Rahman Izaini Ghani and Jafri Malin Abdullah",reviewType:"peer-reviewed",authors:[{id:"42580",title:"Prof.",name:"Jafri",middleName:"Malin",surname:"Abdullah",fullName:"Jafri Abdullah",slug:"jafri-abdullah"},{id:"73844",title:"Prof.",name:"Zamzuri",middleName:null,surname:"Idris",fullName:"Zamzuri Idris",slug:"zamzuri-idris"},{id:"76920",title:"Dr.",name:"Muzaimi",middleName:null,surname:"Mustapha",fullName:"Muzaimi Mustapha",slug:"muzaimi-mustapha"},{id:"155858",title:"Dr.",name:"Rahman I",middleName:null,surname:"Ghani",fullName:"Rahman I Ghani",slug:"rahman-i-ghani"},{id:"155861",title:"Dr.",name:"Badrisyah",middleName:null,surname:"Idris",fullName:"Badrisyah Idris",slug:"badrisyah-idris"},{id:"156254",title:"Dr.",name:"W M Nazaruddin",middleName:null,surname:"W Hassan",fullName:"W M Nazaruddin W Hassan",slug:"w-m-nazaruddin-w-hassan"}]},{id:"41050",type:"chapter",title:"Modern Neuroimaging Techniques in The Diagnosis of Brain Tumours",slug:"modern-neuroimaging-techniques-in-the-diagnosis-of-brain-tumours",totalDownloads:1950,totalCrossrefCites:4,signatures:"Concetta Alafaci, Francesca Granata, Mariano Cutugno, Maria Caffo, Gerardo Caruso and Francesco Maria Salpietro",reviewType:"peer-reviewed",authors:[{id:"54268",title:"Prof.",name:"Concetta",middleName:null,surname:"Alafaci",fullName:"Concetta Alafaci",slug:"concetta-alafaci"},{id:"36309",title:"Dr.",name:"Gerardo",middleName:null,surname:"Caruso",fullName:"Gerardo Caruso",slug:"gerardo-caruso"},{id:"54267",title:"Prof.",name:"Mariella",middleName:null,surname:"Caffo",fullName:"Mariella Caffo",slug:"mariella-caffo"},{id:"159267",title:"Dr.",name:"Francesca",middleName:null,surname:"Granata",fullName:"Francesca Granata",slug:"francesca-granata"},{id:"159271",title:"Dr.",name:"Mariano",middleName:null,surname:"Cutugno",fullName:"Mariano Cutugno",slug:"mariano-cutugno"},{id:"159273",title:"Prof.",name:"Francesco Maria",middleName:null,surname:"Salpietro",fullName:"Francesco Maria Salpietro",slug:"francesco-maria-salpietro"}]},{id:"43882",type:"chapter",title:"Radiology Imaging Techniques of Brain Tumours",slug:"radiology-imaging-techniques-of-brain-tumours",totalDownloads:5885,totalCrossrefCites:1,signatures:"Kamil Zeleňák, Cisáriková Viera and Poláček Hubert",reviewType:"peer-reviewed",authors:[{id:"53229",title:"Dr.",name:"Kamil",middleName:null,surname:"Zeleňák",fullName:"Kamil Zeleňák",slug:"kamil-zelenak"},{id:"160058",title:"Dr.",name:"Viera",middleName:null,surname:"Cisáriková",fullName:"Viera Cisáriková",slug:"viera-cisarikova"},{id:"160061",title:"Dr.",name:"Hubert",middleName:null,surname:"Poláček",fullName:"Hubert Poláček",slug:"hubert-polacek"}]},{id:"43933",type:"chapter",title:"Recent Developments of Single Photon Emission Computed Tomography for the Diagnosis of Brain Tumors",slug:"recent-developments-of-single-photon-emission-computed-tomography-for-the-diagnosis-of-brain-tumors",totalDownloads:1450,totalCrossrefCites:0,signatures:"Yasushi Shibata",reviewType:"peer-reviewed",authors:[{id:"157064",title:"Prof.",name:"Yasushi",middleName:null,surname:"Shibata",fullName:"Yasushi Shibata",slug:"yasushi-shibata"}]},{id:"43886",type:"chapter",title:"Pilocytic Astrocytoma: Anatomic, Pathological and Molecular Aspects",slug:"pilocytic-astrocytoma-anatomic-pathological-and-molecular-aspects",totalDownloads:4115,totalCrossrefCites:0,signatures:"Aline Paixao Becker, Cristovam Scapulatempo-Neto, Luciano Neder, Leila Chimelli and Rui M. Reis",reviewType:"peer-reviewed",authors:[{id:"35397",title:"Prof.",name:"Rui",middleName:null,surname:"Reis",fullName:"Rui Reis",slug:"rui-reis"}]},{id:"43906",type:"chapter",title:"Histology of Primary Brain Tumors",slug:"histology-of-primary-brain-tumors",totalDownloads:5587,totalCrossrefCites:3,signatures:"Maysa Al-Hussaini",reviewType:"peer-reviewed",authors:[{id:"35548",title:"Dr.",name:"Maysa",middleName:null,surname:"Al-Hussaini",fullName:"Maysa Al-Hussaini",slug:"maysa-al-hussaini"}]},{id:"43907",type:"chapter",title:"Surgical Treatment for Multiple Brain Metastases",slug:"surgical-treatment-for-multiple-brain-metastases",totalDownloads:1761,totalCrossrefCites:0,signatures:"Takeshi Okuda and Amami Kato",reviewType:"peer-reviewed",authors:[{id:"51961",title:"Dr.",name:"Takeshi",middleName:null,surname:"Okuda",fullName:"Takeshi Okuda",slug:"takeshi-okuda"}]},{id:"38876",type:"chapter",title:"Metastatic Brain Tumors",slug:"metastatic-brain-tumors",totalDownloads:1472,totalCrossrefCites:0,signatures:"Steven N. Kalkanis and Sanjay Patra",reviewType:"peer-reviewed",authors:[{id:"156239",title:"Dr",name:null,middleName:null,surname:"Kalkanis",fullName:"Kalkanis",slug:"kalkanis"},{id:"156240",title:"Dr.",name:"Sanjay",middleName:null,surname:"Patra",fullName:"Sanjay Patra",slug:"sanjay-patra"}]},{id:"43908",type:"chapter",title:"Tumor Associated Epilepsy",slug:"tumor-associated-epilepsy",totalDownloads:1557,totalCrossrefCites:0,signatures:"Edward K. Avila",reviewType:"peer-reviewed",authors:[{id:"157814",title:"Dr",name:null,middleName:null,surname:"Avila",fullName:"Avila",slug:"avila"}]},{id:"43909",type:"chapter",title:"Glioma-Associated Epilepsy",slug:"glioma-associated-epilepsy",totalDownloads:1837,totalCrossrefCites:0,signatures:"Kost Elisevich",reviewType:"peer-reviewed",authors:[{id:"155192",title:"Prof.",name:"Kost",middleName:null,surname:"Elisevich",fullName:"Kost Elisevich",slug:"kost-elisevich"}]},{id:"43910",type:"chapter",title:"Current Applications of 5-ALA in Glioma Diagnostics and Therapy",slug:"current-applications-of-5-ala-in-glioma-diagnostics-and-therapy",totalDownloads:2331,totalCrossrefCites:2,signatures:"Lei Teng, Mitsutoshi Nakada, Yutaka Hayashi, Takeshi Yoneyama, Shi-Guang Zhao and Jun-Ichiro Hamada",reviewType:"peer-reviewed",authors:[{id:"43162",title:"Prof.",name:"Mitsutoshi",middleName:null,surname:"Nakada",fullName:"Mitsutoshi Nakada",slug:"mitsutoshi-nakada"}]},{id:"43911",type:"chapter",title:"Photodynamic Therapy Using Talaporfin Sodium and Diode Laser for Newly Diagnosed Malignant Gliomas",slug:"photodynamic-therapy-using-talaporfin-sodium-and-diode-laser-for-newly-diagnosed-malignant-gliomas",totalDownloads:2086,totalCrossrefCites:0,signatures:"Jiro Akimoto",reviewType:"peer-reviewed",authors:[{id:"46919",title:"Dr.",name:"Jiro",middleName:null,surname:"Akimoto",fullName:"Jiro Akimoto",slug:"jiro-akimoto"}]},{id:"43921",type:"chapter",title:"Epithelial to Mesenchymal Transition and Progression of Glioblastoma",slug:"epithelial-to-mesenchymal-transition-and-progression-of-glioblastoma",totalDownloads:2749,totalCrossrefCites:2,signatures:"Andrej Pala, Georg Karpel-Massler, Christian Rainer Wirtz and Marc- Eric Halatsch",reviewType:"peer-reviewed",authors:[{id:"35183",title:"Dr.",name:"Georg",middleName:null,surname:"Karpel-Massler",fullName:"Georg Karpel-Massler",slug:"georg-karpel-massler"},{id:"48440",title:"Prof.",name:"Marc-Eric",middleName:null,surname:"Halatsch",fullName:"Marc-Eric Halatsch",slug:"marc-eric-halatsch"},{id:"158099",title:"Dr.",name:"Andrej",middleName:null,surname:"Pala",fullName:"Andrej Pala",slug:"andrej-pala"},{id:"166849",title:"Prof.",name:"Christian Rainer",middleName:null,surname:"Wirtz",fullName:"Christian Rainer Wirtz",slug:"christian-rainer-wirtz"}]},{id:"43923",type:"chapter",title:"Laboratory Testing for Prognostic and Predictive Markers in Gliomas",slug:"laboratory-testing-for-prognostic-and-predictive-markers-in-gliomas",totalDownloads:1837,totalCrossrefCites:0,signatures:"Milena Cankovic",reviewType:"peer-reviewed",authors:[{id:"157582",title:"Dr",name:"Milena",middleName:null,surname:"Cankovic",fullName:"Milena Cankovic",slug:"milena-cankovic"}]},{id:"43928",type:"chapter",title:"Telomeres and Brain Tumors",slug:"telomeres-and-brain-tumors",totalDownloads:1615,totalCrossrefCites:0,signatures:"Domenico La Torre, Giovanni Raffa, Chiara Tomasello, M’Hammed Aguennouz and Antonino Germano",reviewType:"peer-reviewed",authors:[{id:"54948",title:"Dr.",name:"Domenico",middleName:null,surname:"La Torre",fullName:"Domenico La Torre",slug:"domenico-la-torre"}]},{id:"43953",type:"chapter",title:"Chromosomal Analysis: Clinical Applicability to Brain Cancers",slug:"chromosomal-analysis-clinical-applicability-to-brain-cancers",totalDownloads:2411,totalCrossrefCites:1,signatures:"Fabio P. Estumano da Silva and Edivaldo H. C. de Oliveira",reviewType:"peer-reviewed",authors:[{id:"158040",title:"Dr.",name:"Edivaldo",middleName:"Herculano Correa",surname:"De Oliveira",fullName:"Edivaldo De Oliveira",slug:"edivaldo-de-oliveira"},{id:"158042",title:"MSc.",name:"Fabio",middleName:null,surname:"Da Silva",fullName:"Fabio Da Silva",slug:"fabio-da-silva"}]},{id:"43962",type:"chapter",title:"Brainstem Gliomas",slug:"brainstem-gliomas",totalDownloads:3033,totalCrossrefCites:0,signatures:"Zhiping Zhou and Mark M. Souweidane",reviewType:"peer-reviewed",authors:[{id:"45389",title:"Dr.",name:"Mark",middleName:"M.",surname:"Souweidane",fullName:"Mark Souweidane",slug:"mark-souweidane"},{id:"158907",title:"Dr.",name:"Zhiping",middleName:null,surname:"Zhou",fullName:"Zhiping Zhou",slug:"zhiping-zhou"}]},{id:"43963",type:"chapter",title:"Chemotherapeutic Agent for Glioma",slug:"chemotherapeutic-agent-for-glioma",totalDownloads:2753,totalCrossrefCites:1,signatures:"Shinji Kohsaka and Shinya Tanaka",reviewType:"peer-reviewed",authors:[{id:"49655",title:"Prof.",name:"Shinya",middleName:null,surname:"Tanaka",fullName:"Shinya Tanaka",slug:"shinya-tanaka"},{id:"161991",title:"Dr.",name:"Shinji",middleName:null,surname:"Kohsaka",fullName:"Shinji Kohsaka",slug:"shinji-kohsaka"}]},{id:"43965",type:"chapter",title:"Topoisomerase Therapy in the Treatment of Brain Tumors",slug:"topoisomerase-therapy-in-the-treatment-of-brain-tumors",totalDownloads:1570,totalCrossrefCites:1,signatures:"George Theodore, Niramol Savaraj and Lynn Feun",reviewType:"peer-reviewed",authors:[{id:"162096",title:"Dr.",name:"George",middleName:null,surname:"Theodore",fullName:"George Theodore",slug:"george-theodore"},{id:"162110",title:"Dr.",name:"Lynn",middleName:null,surname:"Feun",fullName:"Lynn Feun",slug:"lynn-feun"}]},{id:"43966",type:"chapter",title:"Primary Central Nervous System Lymphoma − Recent Advance on Clinical Research",slug:"primary-central-nervous-system-lymphoma-recent-advance-on-clinical-research",totalDownloads:1722,totalCrossrefCites:1,signatures:"Ryuya Yamanaka",reviewType:"peer-reviewed",authors:[{id:"41282",title:"Dr.",name:"Ryuya",middleName:null,surname:"Yamanaka",fullName:"Ryuya Yamanaka",slug:"ryuya-yamanaka"}]},{id:"43967",type:"chapter",title:"Contributions to the Understanding of the Neural Bases of the Consciousness",slug:"contributions-to-the-understanding-of-the-neural-bases-of-the-consciousness",totalDownloads:2111,totalCrossrefCites:1,signatures:"Leon Dănăilă and Mihail Lucian Pascu",reviewType:"peer-reviewed",authors:[{id:"41760",title:"Dr.",name:"Mihail - Lucian",middleName:null,surname:"Pascu",fullName:"Mihail - Lucian Pascu",slug:"mihail-lucian-pascu"}]},{id:"43969",type:"chapter",title:"The Stance of Antioxidants in Brain Tumors",slug:"the-stance-of-antioxidants-in-brain-tumors",totalDownloads:2427,totalCrossrefCites:0,signatures:"Pinar Atukeren and M. Ramazan Yigitoglu",reviewType:"peer-reviewed",authors:[{id:"54960",title:"Dr.",name:"Pınar",middleName:null,surname:"Atukeren",fullName:"Pınar Atukeren",slug:"pinar-atukeren"},{id:"163866",title:"Dr.",name:"M.Ramazan",middleName:null,surname:"Yigitoglu",fullName:"M.Ramazan Yigitoglu",slug:"m.ramazan-yigitoglu"}]},{id:"43971",type:"chapter",title:"Management of Brain Tumor in Pregnancy — An Anesthesia Window",slug:"management-of-brain-tumor-in-pregnancy-an-anesthesia-window",totalDownloads:2265,totalCrossrefCites:1,signatures:"Hala M. Goma",reviewType:"peer-reviewed",authors:[{id:"42540",title:"Dr.",name:"Hala",middleName:"Mostafa",surname:"Goma",fullName:"Hala Goma",slug:"hala-goma"},{id:"162798",title:"Prof.",name:"Amr",middleName:null,surname:"Abo Ela",fullName:"Amr Abo Ela",slug:"amr-abo-ela"}]},{id:"44038",type:"chapter",title:"Interdisciplinary Surgical Management of Orbital and Maxillo- Ethmoidal Complex Disorders",slug:"interdisciplinary-surgical-management-of-orbital-and-maxillo-ethmoidal-complex-disorders",totalDownloads:3824,totalCrossrefCites:1,signatures:"Jarosław Paluch, Jarosław Markowski, Jan Pilch, Agnieszka Piotrowska – Seweryn, Robert Kwiatkowski, Joanna Lewin-Kowalik, Czesław Zralek and Agnieszka Gorzkowska",reviewType:"peer-reviewed",authors:[{id:"46014",title:"Prof.",name:"Jarosław",middleName:null,surname:"Markowski",fullName:"Jarosław Markowski",slug:"jaroslaw-markowski"},{id:"55851",title:"Dr.",name:"Jarosław",middleName:null,surname:"Paluch",fullName:"Jarosław Paluch",slug:"jaroslaw-paluch"},{id:"165065",title:"Dr.",name:"Agnieszka",middleName:null,surname:"Piotrowska - Seweryn",fullName:"Agnieszka Piotrowska - Seweryn",slug:"agnieszka-piotrowska-seweryn"},{id:"166896",title:"Prof.",name:"Joanna",middleName:null,surname:"Lewin-Kowalik",fullName:"Joanna Lewin-Kowalik",slug:"joanna-lewin-kowalik"},{id:"166897",title:"Dr.",name:"Włodzimierz",middleName:null,surname:"Dziubdziela",fullName:"Włodzimierz Dziubdziela",slug:"wlodzimierz-dziubdziela"},{id:"166944",title:"Dr.",name:"Maciej",middleName:null,surname:"Kajor",fullName:"Maciej Kajor",slug:"maciej-kajor"},{id:"166955",title:"Dr.",name:"Czesław",middleName:null,surname:"Zralek",fullName:"Czesław Zralek",slug:"czeslaw-zralek"},{id:"166968",title:"Dr.",name:"Robert",middleName:null,surname:"Kwiatkowski",fullName:"Robert Kwiatkowski",slug:"robert-kwiatkowski"},{id:"167226",title:"Prof.",name:"Jan",middleName:null,surname:"Pilch",fullName:"Jan Pilch",slug:"jan-pilch"}]},{id:"43805",type:"chapter",title:"The Epidemiology of Paediatric Brain Cancer — Descriptive Epidemiology and Risk Factors",slug:"the-epidemiology-of-paediatric-brain-cancer-descriptive-epidemiology-and-risk-factors",totalDownloads:1618,totalCrossrefCites:1,signatures:"Adrianna Ranger",reviewType:"peer-reviewed",authors:[{id:"40865",title:"Dr.",name:"Adrianna",middleName:null,surname:"Ranger",fullName:"Adrianna Ranger",slug:"adrianna-ranger"}]}]},relatedBooks:[{type:"book",id:"3510",title:"Evolution of the Molecular Biology of Brain Tumors and the Therapeutic Implications",subtitle:null,isOpenForSubmission:!1,hash:"55fec67e081aaf4092d93187b20ab6d1",slug:"evolution-of-the-molecular-biology-of-brain-tumors-and-the-therapeutic-implications",bookSignature:"Terry Lichtor",coverURL:"https://cdn.intechopen.com/books/images_new/3510.jpg",editedByType:"Edited by",editors:[{id:"37886",title:"Dr.",name:"Terry",surname:"Lichtor",slug:"terry-lichtor",fullName:"Terry Lichtor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"43049",title:"Brain Tumor Invasion and Angiogenesis",slug:"brain-tumor-invasion-and-angiogenesis",signatures:"Almos Klekner",authors:[{id:"155547",title:"Associate Prof.",name:"Almos",middleName:null,surname:"Klekner",fullName:"Almos Klekner",slug:"almos-klekner"}]},{id:"42916",title:"Gliomas Biology: Angiogenesis and Invasion",slug:"gliomas-biology-angiogenesis-and-invasion",signatures:"Maria Caffo, Valeria Barresi, Gerardo Caruso, Giuseppe La Fata, Maria Angela Pino, Giuseppe Raudino, Concetta Alafaci and Francesco Tomasello",authors:[{id:"36309",title:"Dr.",name:"Gerardo",middleName:null,surname:"Caruso",fullName:"Gerardo Caruso",slug:"gerardo-caruso"},{id:"54267",title:"Prof.",name:"Mariella",middleName:null,surname:"Caffo",fullName:"Mariella Caffo",slug:"mariella-caffo"},{id:"54268",title:"Prof.",name:"Concetta",middleName:null,surname:"Alafaci",fullName:"Concetta Alafaci",slug:"concetta-alafaci"},{id:"60567",title:"Dr.",name:"Giuseppe",middleName:null,surname:"Raudino",fullName:"Giuseppe Raudino",slug:"giuseppe-raudino"},{id:"159267",title:"Dr.",name:"Francesca",middleName:null,surname:"Granata",fullName:"Francesca Granata",slug:"francesca-granata"},{id:"160023",title:"Prof.",name:"Valeria",middleName:null,surname:"Barresi",fullName:"Valeria Barresi",slug:"valeria-barresi"},{id:"160024",title:"Prof.",name:"Mario",middleName:null,surname:"Venza",fullName:"Mario Venza",slug:"mario-venza"}]},{id:"42918",title:"Hypoxia, Angiogenesis and Mechanisms for Invasion of Malignant Gliomas",slug:"hypoxia-angiogenesis-and-mechanisms-for-invasion-of-malignant-gliomas",signatures:"Paula Province, Corinne E. Griguer, Xiaosi Han, Nabors Louis B. and Hassan Fathallah Shaykh",authors:[{id:"50232",title:"Prof.",name:"Hassan",middleName:"Mahmoud",surname:"Fathallah-Shaykh",fullName:"Hassan Fathallah-Shaykh",slug:"hassan-fathallah-shaykh"}]},{id:"42821",title:"Brain Tumor–Induced Angiogenesis: Approaches and Bioassays",slug:"brain-tumor-induced-angiogenesis-approaches-and-bioassays",signatures:"Stefan W. Hock, Zheng Fan, Michael Buchfelder, Ilker Y. Eyüpoglu and Nic E. Savaskan",authors:[{id:"158526",title:"Dr.",name:"Nicolai",middleName:"E.",surname:"Savaskan",fullName:"Nicolai Savaskan",slug:"nicolai-savaskan"}]},{id:"42933",title:"IGF-I Antisense and Triple-Helix Gene Therapy of Glioblastoma",slug:"igf-i-antisense-and-triple-helix-gene-therapy-of-glioblastoma",signatures:"Jerzy Trojan and Ignacio Briceno",authors:[{id:"160811",title:"Dr.",name:"Jerzy",middleName:null,surname:"Trojan",fullName:"Jerzy Trojan",slug:"jerzy-trojan"}]},{id:"43006",title:"Using REMBRANDT to Paint in the Details of Glioma Biology: Applications for Future Immunotherapy",slug:"using-rembrandt-to-paint-in-the-details-of-glioma-biology-applications-for-future-immunotherapy",signatures:"An Q. Dang, Neil T. Hoa, Lisheng Ge, Gabriel Arismendi Morillo, Brian Paleo, Esteban J. Gomez, Dayeon Judy Shon, Erin Hong, Ahmed M. Aref and Martin R. Jadus",authors:[{id:"155197",title:"Dr.",name:"Martin",middleName:null,surname:"Jadus",fullName:"Martin Jadus",slug:"martin-jadus"}]},{id:"43055",title:"From Gliomagenesis to Multimodal Therapeutic Approaches into High-Grade Glioma Treatment",slug:"from-gliomagenesis-to-multimodal-therapeutic-approaches-into-high-grade-glioma-treatment",signatures:"Giuseppe Raudino, Maria Caffo, Gerardo Caruso, Concetta Alafaci, Federica Raudino, Valentina Marventano, Alberto Romano, Francesco Montemagno, Massimo Belvedere, Francesco Maria Salpietro, Francesco Tomasello and Anna Schillaci",authors:[{id:"36309",title:"Dr.",name:"Gerardo",middleName:null,surname:"Caruso",fullName:"Gerardo Caruso",slug:"gerardo-caruso"},{id:"54267",title:"Prof.",name:"Mariella",middleName:null,surname:"Caffo",fullName:"Mariella Caffo",slug:"mariella-caffo"},{id:"54268",title:"Prof.",name:"Concetta",middleName:null,surname:"Alafaci",fullName:"Concetta Alafaci",slug:"concetta-alafaci"},{id:"60567",title:"Dr.",name:"Giuseppe",middleName:null,surname:"Raudino",fullName:"Giuseppe Raudino",slug:"giuseppe-raudino"},{id:"159273",title:"Prof.",name:"Francesco Maria",middleName:null,surname:"Salpietro",fullName:"Francesco Maria Salpietro",slug:"francesco-maria-salpietro"},{id:"159276",title:"Prof.",name:"Francesco",middleName:null,surname:"Tomasello",fullName:"Francesco Tomasello",slug:"francesco-tomasello"},{id:"167490",title:"Mrs.",name:"Federica",middleName:null,surname:"Raudino",fullName:"Federica Raudino",slug:"federica-raudino"},{id:"167491",title:"Mrs.",name:"Valentina",middleName:null,surname:"Marventano",fullName:"Valentina Marventano",slug:"valentina-marventano"},{id:"167492",title:"Dr.",name:"Alberto",middleName:null,surname:"Romano",fullName:"Alberto Romano",slug:"alberto-romano"},{id:"167493",title:"Dr.",name:"Francesco",middleName:null,surname:"Montemagno",fullName:"Francesco Montemagno",slug:"francesco-montemagno"},{id:"167494",title:"Dr.",name:"Massimo",middleName:null,surname:"Belvedere",fullName:"Massimo Belvedere",slug:"massimo-belvedere"},{id:"167495",title:"Dr.",name:"Anna",middleName:null,surname:"Schillaci",fullName:"Anna Schillaci",slug:"anna-schillaci"}]},{id:"43250",title:"Dipeptidyl Peptidase-IV and Related Proteases in Brain Tumors",slug:"dipeptidyl-peptidase-iv-and-related-proteases-in-brain-tumors",signatures:"Petr Busek and Aleksi Sedo",authors:[{id:"43716",title:"Prof.",name:"Aleksi",middleName:null,surname:"Sedo",fullName:"Aleksi Sedo",slug:"aleksi-sedo"},{id:"58715",title:"Dr.",name:"Petr",middleName:null,surname:"Busek",fullName:"Petr Busek",slug:"petr-busek"}]},{id:"42935",title:"Apoptotic Events in Glioma Activate Metalloproteinases and Enhance Invasiveness",slug:"apoptotic-events-in-glioma-activate-metalloproteinases-and-enhance-invasiveness",signatures:"Albert Magro",authors:[{id:"158432",title:"Prof.",name:"Albert",middleName:null,surname:"Magro",fullName:"Albert Magro",slug:"albert-magro"}]},{id:"42971",title:"The Distribution and Significance of IDH Mutations in Gliomas",slug:"the-distribution-and-significance-of-idh-mutations-in-gliomas",signatures:"Marta Mellai, Valentina Caldera, Laura Annovazzi and Davide Schiffer",authors:[{id:"50128",title:"Prof.",name:"Davide",middleName:null,surname:"Schiffer",fullName:"Davide Schiffer",slug:"davide-schiffer"}]},{id:"42938",title:"Deregulation of Cell Polarity Proteins in Gliomagenesis",slug:"deregulation-of-cell-polarity-proteins-in-gliomagenesis",signatures:"Khamushavalli Geevimaan and Phanithi Prakash Babu",authors:[{id:"47201",title:"Dr.",name:"Phanithi Prakash",middleName:null,surname:"Babu",fullName:"Phanithi Prakash Babu",slug:"phanithi-prakash-babu"}]},{id:"42939",title:"Aquaporin, Midkine and Glioblastoma",slug:"aquaporin-midkine-and-glioblastoma",signatures:"Mine Ergüven",authors:[{id:"44074",title:"Associate Prof.",name:"Mine",middleName:null,surname:"Erguven",fullName:"Mine Erguven",slug:"mine-erguven"}]},{id:"38839",title:"Porphyrin Synthesis from 5-Aminolevulinic Acid in Patients with Glioma",slug:"porphyrin-synthesis-from-5-aminolevulinic-acid-in-patients-with-glioma",signatures:"Satoshi Utsuki, Hidehiro Oka, Kiyotaka Fujii, Norio Miyoshi, Masahiro Ishizuka, Kiwamu Takahashi and Katsushi Inoue",authors:[{id:"36193",title:"Dr.",name:"Satoshi",middleName:null,surname:"Utsuki",fullName:"Satoshi Utsuki",slug:"satoshi-utsuki"}]},{id:"42975",title:"Mechanisms of Aggressiveness in Glioblastoma: Prognostic and Potential Therapeutic Insights",slug:"mechanisms-of-aggressiveness-in-glioblastoma-prognostic-and-potential-therapeutic-insights",signatures:"Céline S. Gonçalves, Tatiana Lourenço, Ana Xavier-Magalhães, Marta Pojo and Bruno M. Costa",authors:[{id:"42804",title:"Dr.",name:"Bruno",middleName:null,surname:"Costa",fullName:"Bruno Costa",slug:"bruno-costa"}]},{id:"42946",title:"A Rational for Novel Anti-NeuroOncology Drugs",slug:"a-rational-for-novel-anti-neurooncology-drugs",signatures:"Lee Roy Morgan",authors:[{id:"158053",title:"Dr.",name:"Lee Roy",middleName:null,surname:"Morgan",fullName:"Lee Roy Morgan",slug:"lee-roy-morgan"}]},{id:"42953",title:"DNA-PK is a Potential Molecular Therapeutic Target for Glioblastoma",slug:"dna-pk-is-a-potential-molecular-therapeutic-target-for-glioblastoma",signatures:"P. O. Carminati, F. S. Donaires, P. R. D. V. Godoy, A. P. Montaldi, J. A. Meador, A.S. Balajee, G. A. Passos and E. T. Sakamoto-Hojo",authors:[{id:"40857",title:"Dr.",name:"Adayabalam",middleName:null,surname:"Balajee",fullName:"Adayabalam Balajee",slug:"adayabalam-balajee"},{id:"47245",title:"Dr.",name:"Elza",middleName:"Tiemi",surname:"Sakamoto-Hojo",fullName:"Elza Sakamoto-Hojo",slug:"elza-sakamoto-hojo"},{id:"53465",title:"M.Sc.",name:"Paulo Roberto",middleName:"D´Auria Vieira",surname:"Godoy",fullName:"Paulo Roberto Godoy",slug:"paulo-roberto-godoy"},{id:"53475",title:"MSc.",name:"Ana Paula",middleName:null,surname:"Montaldi",fullName:"Ana Paula Montaldi",slug:"ana-paula-montaldi"},{id:"166605",title:"Dr.",name:"Geraldo",middleName:null,surname:"Passos",fullName:"Geraldo Passos",slug:"geraldo-passos"},{id:"166606",title:"MSc.",name:"Flávia",middleName:null,surname:"Donaires",fullName:"Flávia Donaires",slug:"flavia-donaires"},{id:"166607",title:"Dr.",name:"Patrícia",middleName:null,surname:"Carminati",fullName:"Patrícia Carminati",slug:"patricia-carminati"},{id:"166608",title:"Dr.",name:"Jarah",middleName:null,surname:"Meador",fullName:"Jarah Meador",slug:"jarah-meador"}]},{id:"42984",title:"Evolvement of microRNAs as Therapeutic Targets for Malignant Gliomas",slug:"evolvement-of-micrornas-as-therapeutic-targets-for-malignant-gliomas",signatures:"Sihan Wu, Wenbo Zhu and Guangmei Yan",authors:[{id:"42293",title:"Prof.",name:"Guangmei",middleName:null,surname:"Yan",fullName:"Guangmei Yan",slug:"guangmei-yan"},{id:"43211",title:"Dr.",name:"Wenbo",middleName:null,surname:"Zhu",fullName:"Wenbo Zhu",slug:"wenbo-zhu"},{id:"158661",title:"BSc.",name:"Sihan",middleName:null,surname:"Wu",fullName:"Sihan Wu",slug:"sihan-wu"}]},{id:"42965",title:"MicroRNAs Regulated Brain Tumor Cell Phenotype and Their Therapeutic Potential",slug:"micrornas-regulated-brain-tumor-cell-phenotype-and-their-therapeutic-potential",signatures:"Chunzhi Zhang, Budong Chen, Xiangying Xu, Baolin Han, Guangshun Wang and Jinhuan Wang",authors:[{id:"54052",title:"Dr.",name:"Chunzhi",middleName:null,surname:"Zhang",fullName:"Chunzhi Zhang",slug:"chunzhi-zhang"}]},{id:"42966",title:"Carbonic Anhydrase IX in Adult and Pediatric Brain Tumors",slug:"carbonic-anhydrase-ix-in-adult-and-pediatric-brain-tumors",signatures:"Kristiina Nordfors, Joonas Haapasalo, Hannu Haapasalo and Seppo Parkkila",authors:[{id:"158251",title:"Ph.D.",name:"Joonas",middleName:null,surname:"Haapasalo",fullName:"Joonas Haapasalo",slug:"joonas-haapasalo"},{id:"158253",title:"Dr.",name:"Kristiina",middleName:null,surname:"Nordfors",fullName:"Kristiina Nordfors",slug:"kristiina-nordfors"},{id:"158254",title:"Dr.",name:"Hannu",middleName:null,surname:"Haapasalo",fullName:"Hannu Haapasalo",slug:"hannu-haapasalo"},{id:"158255",title:"Prof.",name:"Seppo",middleName:null,surname:"Parkkila",fullName:"Seppo Parkkila",slug:"seppo-parkkila"}]},{id:"42988",title:"New Molecular Targets and Treatments for Pediatric Brain Tumors",slug:"new-molecular-targets-and-treatments-for-pediatric-brain-tumors",signatures:"Claudia C. Faria, Christian A. Smith and James T. Rutka",authors:[{id:"51475",title:"Dr.",name:"James",middleName:null,surname:"Rutka",fullName:"James Rutka",slug:"james-rutka"}]},{id:"43061",title:"In silico Analysis of Transcription Factors Associated to Differentially Expressed Genes in Irradiated Glioblastoma Cell Lines",slug:"in-silico-analysis-of-transcription-factors-associated-to-differentially-expressed-genes-in-irradiat",signatures:"P. R. D. V. Godoy, S. S. Mello, F. S. Donaires, E. A. Donadi, G. A. S. Passos and E. T. Sakamoto-Hojo",authors:[{id:"47245",title:"Dr.",name:"Elza",middleName:"Tiemi",surname:"Sakamoto-Hojo",fullName:"Elza Sakamoto-Hojo",slug:"elza-sakamoto-hojo"},{id:"53465",title:"M.Sc.",name:"Paulo Roberto",middleName:"D´Auria Vieira",surname:"Godoy",fullName:"Paulo Roberto Godoy",slug:"paulo-roberto-godoy"},{id:"166606",title:"MSc.",name:"Flávia",middleName:null,surname:"Donaires",fullName:"Flávia Donaires",slug:"flavia-donaires"},{id:"53468",title:"Dr.",name:"Stephano",middleName:"Spano",surname:"Mello",fullName:"Stephano Mello",slug:"stephano-mello"},{id:"53483",title:"Dr.",name:"Geraldo",middleName:null,surname:"Passos",fullName:"Geraldo Passos",slug:"geraldo-passos"},{id:"166609",title:"Dr.",name:"Eduardo",middleName:null,surname:"Donadi",fullName:"Eduardo Donadi",slug:"eduardo-donadi"}]},{id:"41922",title:"Brain Tumor Stemness",slug:"brain-tumor-stemness",signatures:"Andrés Felipe Cardona and León Darío Ortíz",authors:[{id:"40884",title:"Dr.",name:"LEON DARIO",middleName:null,surname:"ORTIZ",fullName:"LEON DARIO ORTIZ",slug:"leon-dario-ortiz"},{id:"40885",title:"Mr.",name:"Andres F.",middleName:null,surname:"Cardona",fullName:"Andres F. Cardona",slug:"andres-f.-cardona"}]},{id:"42974",title:"Nestin: Neural Stem/Progenitor Cell Marker in Brain Tumors",slug:"nestin-neural-stem-progenitor-cell-marker-in-brain-tumors",signatures:"Yoko Matsuda, Hisashi Yoshimura, Taeko Suzuki and Toshiyuki Ishiwata",authors:[{id:"157218",title:"Associate Prof.",name:"Toshiyuki",middleName:null,surname:"Ishiwata",fullName:"Toshiyuki Ishiwata",slug:"toshiyuki-ishiwata"},{id:"158970",title:"Dr.",name:"Yoko",middleName:null,surname:"Matsuda",fullName:"Yoko Matsuda",slug:"yoko-matsuda"},{id:"158972",title:"Dr.",name:"Hisashi",middleName:null,surname:"Yoshimura",fullName:"Hisashi Yoshimura",slug:"hisashi-yoshimura"}]}]}],publishedBooks:[{type:"book",id:"3277",title:"Clinical Management and Evolving Novel Therapeutic Strategies for Patients with Brain Tumors",subtitle:null,isOpenForSubmission:!1,hash:"0e1a016e5ad3e9dcbbc94c20cd188ee5",slug:"clinical-management-and-evolving-novel-therapeutic-strategies-for-patients-with-brain-tumors",bookSignature:"Terry Lichtor",coverURL:"https://cdn.intechopen.com/books/images_new/3277.jpg",editedByType:"Edited by",editors:[{id:"37886",title:"Dr.",name:"Terry",surname:"Lichtor",slug:"terry-lichtor",fullName:"Terry Lichtor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3510",title:"Evolution of the Molecular Biology of Brain Tumors and the Therapeutic Implications",subtitle:null,isOpenForSubmission:!1,hash:"55fec67e081aaf4092d93187b20ab6d1",slug:"evolution-of-the-molecular-biology-of-brain-tumors-and-the-therapeutic-implications",bookSignature:"Terry Lichtor",coverURL:"https://cdn.intechopen.com/books/images_new/3510.jpg",editedByType:"Edited by",editors:[{id:"37886",title:"Dr.",name:"Terry",surname:"Lichtor",slug:"terry-lichtor",fullName:"Terry Lichtor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4490",title:"Molecular Considerations and Evolving Surgical Management Issues in the Treatment of Patients with a Brain Tumor",subtitle:null,isOpenForSubmission:!1,hash:"091b858bd9f3a370312221ba9fd6085f",slug:"molecular-considerations-and-evolving-surgical-management-issues-in-the-treatment-of-patients-with-a-brain-tumor",bookSignature:"Terry Lichtor",coverURL:"https://cdn.intechopen.com/books/images_new/4490.jpg",editedByType:"Edited by",editors:[{id:"37886",title:"Dr.",name:"Terry",surname:"Lichtor",slug:"terry-lichtor",fullName:"Terry Lichtor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5261",title:"Neurooncology",subtitle:"Newer Developments",isOpenForSubmission:!1,hash:"ae1dcb26219bb62290c5a171c87d6936",slug:"neurooncology-newer-developments",bookSignature:"Amit Agrawal",coverURL:"https://cdn.intechopen.com/books/images_new/5261.jpg",editedByType:"Edited by",editors:[{id:"100142",title:"Prof.",name:"Amit",surname:"Agrawal",slug:"amit-agrawal",fullName:"Amit Agrawal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6503",title:"Brain Tumors",subtitle:"An Update",isOpenForSubmission:!1,hash:"055b45888e92391890d4992da9e8a4c3",slug:"brain-tumors-an-update",bookSignature:"Amit Agrawal, Luis Rafael Moscote-Salazar",coverURL:"https://cdn.intechopen.com/books/images_new/6503.jpg",editedByType:"Edited by",editors:[{id:"100142",title:"Prof.",name:"Amit",surname:"Agrawal",slug:"amit-agrawal",fullName:"Amit Agrawal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],publishedBooksByAuthor:[{type:"book",id:"3277",title:"Clinical Management and Evolving Novel Therapeutic Strategies for Patients with Brain Tumors",subtitle:null,isOpenForSubmission:!1,hash:"0e1a016e5ad3e9dcbbc94c20cd188ee5",slug:"clinical-management-and-evolving-novel-therapeutic-strategies-for-patients-with-brain-tumors",bookSignature:"Terry Lichtor",coverURL:"https://cdn.intechopen.com/books/images_new/3277.jpg",editedByType:"Edited by",editors:[{id:"37886",title:"Dr.",name:"Terry",surname:"Lichtor",slug:"terry-lichtor",fullName:"Terry Lichtor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},onlineFirst:{chapter:{type:"chapter",id:"77696",title:"Canceled: Exploring How Human Activities Disturb the Balance of Biogeochemical Cycles: Evidence from the Carbon, Nitrogen and Hydrologic Cycles",doi:"10.5772/intechopen.98533",slug:"canceled-exploring-how-human-activities-disturb-the-balance-of-biogeochemical-cycles-evidence-from-t",body:null,keywords:"Biogeochemical cycles, Human activities, Worst disturbances, Ameliorative measures",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/77696.pdf",chapterXML:null,downloadPdfUrl:"/chapter/pdf-download/77696",previewPdfUrl:"/chapter/pdf-preview/77696",totalDownloads:137,totalViews:0,totalCrossrefCites:0,dateSubmitted:"February 11th 2021",dateReviewed:"May 24th 2021",datePrePublished:"July 28th 2021",datePublished:null,dateFinished:"July 28th 2021",readingETA:"0",abstract:"All around us today there is a clear evidence proof suggesting an observable influence by human on biogeochemical cycles which are likely to cause serious consequences for humanity. Activities of human affects the biogeochemical cycles, both directly as well as indirectly. If scholars were able to make clear the degree of how specific human actions is affecting the biogeochemical cycles, they (researchers) would be able to come up with ideas on how to better position toward suggesting strategies aimed at mitigating against disturbances that are worst. This paper aims at exploring how human activities affect the balance of biogeochemical cycles in relation to the Carbon, Nitrogen and Hydrologic Cycles. A literature analysis attempts to use a diversity of search engines such as Scopus, Researchgate, PubMed, Google Scholar, Summon, Hinari, CAB Abstract, OARE Abstract, Academia, Dimension, Mendeley, SSRN search strategy toward retrieving research publications, “gray literature” as well as expert reports from working group. This paper review some of the work done on this topic as well as locate the converging results of interest in all the studies as well as proffered solutions toward this menace with the purpose of forestalling future occurrence. Due to the actions of numerous human activities, the characteristics/features of several components of biogeochemical cycles are experiencing changes which are most likely led to long-term changes. It is essential to forecast the magnitude as well as degree of these changes so that the needed ameliorative actions could be originated well in time.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/77696",risUrl:"/chapter/ris/77696",signatures:"Raimi Morufu Olalekan, Abiola Ilesanmi, Ogah Alima, Dodeye E. Omini and Aziba-anyam Gift Raimi",book:{id:"9504",type:"book",title:"Science-Based Approaches to Respond to COVID and Other Public Health Threats",subtitle:null,fullTitle:"Science-Based Approaches to Respond to COVID and Other Public Health Threats",slug:"science-based-approaches-to-respond-to-covid-and-other-public-health-threats",publishedDate:"December 1st 2021",bookSignature:"Erick Guerrero",coverURL:"https://cdn.intechopen.com/books/images_new/9504.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-83969-144-7",printIsbn:"978-1-83969-143-0",pdfIsbn:"978-1-83969-145-4",isAvailableForWebshopOrdering:!0,editors:[{id:"294761",title:"Dr.",name:"Erick",middleName:null,surname:"Guerrero",slug:"erick-guerrero",fullName:"Erick Guerrero"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null,sections:null,chapterReferences:null,footnotes:null,contributors:null,corrections:null},book:{id:"9504",type:"book",title:"Science-Based Approaches to Respond to COVID and Other Public Health Threats",subtitle:null,fullTitle:"Science-Based Approaches to Respond to COVID and Other Public Health Threats",slug:"science-based-approaches-to-respond-to-covid-and-other-public-health-threats",publishedDate:"December 1st 2021",bookSignature:"Erick Guerrero",coverURL:"https://cdn.intechopen.com/books/images_new/9504.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-83969-144-7",printIsbn:"978-1-83969-143-0",pdfIsbn:"978-1-83969-145-4",isAvailableForWebshopOrdering:!0,editors:[{id:"294761",title:"Dr.",name:"Erick",middleName:null,surname:"Guerrero",slug:"erick-guerrero",fullName:"Erick Guerrero"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},profile:{item:{id:"218234",title:"Prof.",name:"Marco",middleName:null,surname:"Liberati",email:"liberati@unich.it",fullName:"Marco Liberati",slug:"marco-liberati",position:null,biography:null,institutionString:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",totalCites:0,totalChapterViews:"0",outsideEditionCount:0,totalAuthoredChapters:"1",totalEditedBooks:"0",personalWebsiteURL:null,twitterURL:null,linkedinURL:null,institution:null},booksEdited:[],chaptersAuthored:[{id:"62306",title:"Uterine Sarcomas: An Updated Overview. Part 1: Smooth Muscle Tumors",slug:"uterine-sarcomas-an-updated-overview-part-1-smooth-muscle-tumors",abstract:"Uterine sarcomas (USs) account for 3–9% of uterine malignant neoplasia and about 5% of all gynaecologic malignancies. Despite their low prevalence, these tumors stimulate a great interest because of their aggressiveness, poor prognosis and high mortality rate. According to the last World Health Organization (WHO) classification and the International Federation of Gynecology and Obstetrics Committee (FIGO) staging, USs are categorized as pure mesenchymal tumors (endometrial stromal sarcoma, leiomyosarcoma and undifferentiated uterine), and mixed tumors (carcinosarcoma and adenosarcoma). Due to their non-specific signs and symptoms, USs are commonly diagnosed in advanced stage, more often after surgery for a suspected leiomyoma. Although surgery followed by adjuvant therapies represent the common choices for USs, they show poor efficacy due to the early occurrence of metastasis, and the high resistance of tumors to radio-and chemotherapy. Presently, specific expression profiles and new cytotoxic agents are under investigation. In these reviews, we summarized clinical and pathological features, imaging characteristics, therapeutic approaches, genomic and molecular aberration associated with smooth muscle neoplasia (Part 1) and endometrial stromal neoplasia (Part 2); the goal is to understand the biology and the molecular signature of these tumors, in order to focus on their best management.",signatures:"Roberta Zappacosta, Francesco Fanfani, Barbara Zappacosta,\nFrancesca Sablone, Lucia Pansa, Marco Liberati and Sandra Rosini",authors:[{id:"43833",title:"Prof.",name:"Sandra",surname:"Rosini",fullName:"Sandra Rosini",slug:"sandra-rosini",email:"rosini@unich.it"},{id:"80933",title:"Prof.",name:"Roberta",surname:"Zappacosta",fullName:"Roberta Zappacosta",slug:"roberta-zappacosta",email:"zappacosta2@hotmail.com"},{id:"99169",title:"Dr.",name:"Barbara",surname:"Zappacosta",fullName:"Barbara Zappacosta",slug:"barbara-zappacosta",email:"barbyzappa@libero.it"},{id:"218234",title:"Prof.",name:"Marco",surname:"Liberati",fullName:"Marco Liberati",slug:"marco-liberati",email:"liberati@unich.it"},{id:"218235",title:"Dr.",name:"Francesca",surname:"Sablone",fullName:"Francesca Sablone",slug:"francesca-sablone",email:"francescasablone@hotmail.it"},{id:"218236",title:"Dr.",name:"Lucia",surname:"Pansa",fullName:"Lucia Pansa",slug:"lucia-pansa",email:"luciapansa@libero.it"},{id:"218612",title:"Prof.",name:"Francesco",surname:"Fanfani",fullName:"Francesco Fanfani",slug:"francesco-fanfani",email:"fanfani@unich.it"}],book:{id:"6313",title:"Neoplasm",slug:"neoplasm",productType:{id:"1",title:"Edited Volume"}}}],collaborators:[{id:"43833",title:"Prof.",name:"Sandra",surname:"Rosini",slug:"sandra-rosini",fullName:"Sandra Rosini",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Chieti-Pescara",institutionURL:null,country:{name:"Italy"}}},{id:"80933",title:"Prof.",name:"Roberta",surname:"Zappacosta",slug:"roberta-zappacosta",fullName:"Roberta Zappacosta",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Chieti-Pescara",institutionURL:null,country:{name:"Italy"}}},{id:"99169",title:"Dr.",name:"Barbara",surname:"Zappacosta",slug:"barbara-zappacosta",fullName:"Barbara Zappacosta",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Chieti-Pescara",institutionURL:null,country:{name:"Italy"}}},{id:"214546",title:"Dr.",name:"Zaigham",surname:"Abbas",slug:"zaigham-abbas",fullName:"Zaigham Abbas",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Michigan–Flint",institutionURL:null,country:{name:"United States of America"}}},{id:"214732",title:"Prof.",name:"Monde",surname:"Ntwasa",slug:"monde-ntwasa",fullName:"Monde Ntwasa",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of South Africa",institutionURL:null,country:{name:"South Africa"}}},{id:"214739",title:"Mr.",name:"Phil",surname:"Ubanako",slug:"phil-ubanako",fullName:"Phil Ubanako",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"218235",title:"Dr.",name:"Francesca",surname:"Sablone",slug:"francesca-sablone",fullName:"Francesca Sablone",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"218236",title:"Dr.",name:"Lucia",surname:"Pansa",slug:"lucia-pansa",fullName:"Lucia Pansa",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"218612",title:"Prof.",name:"Francesco",surname:"Fanfani",slug:"francesco-fanfani",fullName:"Francesco Fanfani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"224305",title:"Dr.",name:"Frank Y.",surname:"Shan",slug:"frank-y.-shan",fullName:"Frank Y. Shan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]},generic:{page:{slug:"attribution-policy",title:"Attribution Policy",intro:"Definition of Terms:
\n\nBook - collection of Works distributed in a book format, whose selection, coordination, preparation, and arrangement has been performed and published by IntechOpen, and in which the Work is included in its entirety in an unmodified form along with one or more other contributions, each constituting separate and independent sections, but together assembled into a collective whole.
",metaTitle:"Attribution Policy",metaDescription:"DEFINITION OF TERMS",metaKeywords:null,canonicalURL:"/page/attribution-policy",contentRaw:'[{"type":"htmlEditorComponent","content":"Work - a book Chapter (as well as Conference Papers), including any and all content, graphics, images and/or other materials forming part of, or accompanying, the Chapter/Conference Paper.
\\n\\nAttribution – appropriate credit for the used Work or book.
\\n\\nCreative Commons licenses – enable licensors to retain copyright while allowing others to use their Works in an appropriate way.
\\n\\nRules of Attribution for Works Published by IntechOpen
\\n\\nWith the purpose of protecting Authors' copyright and the transparent reuse of OA (Open Access) content, IntechOpen has developed Rules of Attribution of Works licensed under Creative Commons licenses.
\\n\\n\\n\\t- All Chapters published in IntechOpen books prior to October 2011 are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported license (CC BY-NC-SA 3.0);
\\n\\t- All Chapters published in IntechOpen books after October 2011 are licensed under the Creative Commons Attribution 3.0 Unported license (CC BY 3.0);
\\n
\\n\\nIn case you reuse or republish any of the Works licensed under CC licenses, you must abide by the guidelines outlined below:
\\n\\n1. Rules for reusing of books in their entirety or significant parts of books
\\n\\nAll rights to Books and other compilations published on the IntechOpen platform and in print are reserved by IntechOpen. The Copyright to Books and other compilations is subject to a separate Copyright from any that exists in the included Works.
\\n\\nA Book in its entirety or a significant part of a Book cannot be translated freely without specific written consent by the publisher. Further information can be obtained at permissions@intechopen.com.
\\n\\nIn instances where permission is obtained from the publisher for reusing or republishing the Book, or significant parts of the Book, all of the following conditions apply:
\\n\\n\\n\\t- Information about the first publisher must be provided – please note the fact that the material was originally published by IntechOpen as an OA (Open Access) publication must be acknowledged;
\\n\\t- All original Academic Editor(s) must be credited;
\\n\\t- Since you are reusing content that someone else created and allowed you to use freely, you must credit all Authors involved;
\\n\\t- The type of license that is available for the Works must be indicated, as well as a link to the license provided, so that others can investigate the terms of the license. You will be aware that the material can be used for free in consequence of the CC license attribution, so you must acknowledge that fact. It is not sufficient that the material is Creative Commons, because that says nothing about how the material can actually be used. There are different CC licenses and you have to identify the specific license that is being used;
\\n\\t- Any original Copyright Notices associated, with the Works which constitute the Book must be kept intact;
\\n\\t- Provision of the original title of the Book, as well as the original titles of any individual Works;
\\n\\t- Provision of the URL where the Book is hosted, with a notice to the effect that the Book is an OA (Open Access) publication;
\\n\\t- Provision of the URL to every individual Work which constitutes the Book with a notice that the Work is an OA (Open Access) publication. As the material has been accessed for free, it is incumbent upon you to provide the source so that others can also access it for free.
\\n
\\n\\nEvery single Work that is used has to be attributed in the way described. If you are unsure about proper attribution, please write to permissions@intechopen.com.
\\n\\n2. Rules of attribution for works published by IntechOpen
\\n\\nIndividual Works originally published in IntechOpen books are licensed under Creative Commons licenses and can be freely used under terms of the respective CC license, if properly attributed. In order to properly attribute the Work you must respect all the conditions outlined below:
\\n\\n\\n\\t- Credit all Authors – since you are reusing contents that someone created and allowed you to use freely, you have to acknowledge authorship;
\\n\\t- Indicate the type of license under which the Work is available and provide the URL to the license so others can find out the license terms. Preferably keep intact any original Copyright Notice associated with the Chapter (if any). You will be aware that the material can be used for free in consequence of the CC license attribution, so you must acknowledge that fact. It is not sufficient that the material is Creative Commons, because that says nothing about how the material can actually be used. There are different CC licenses and you have to identify the specific license that is being used;
\\n\\t- Provide the URL where the Work is hosted, preferably providing the original title of the Work, as well as the original title of the Book with a notification that the Work is an OA (Open Access) publication. As the material has been accessed for free, it is incumbent upon you to provide the source so that others can also access it for free;
\\n\\t- Provide information about the first publisher – please note the fact that the material was originally published by IntechOpen as an OA (Open Access) Work must be acknowledged.
\\n
\\n\\nEvery single Work that is used has to be attributed in the way as described. If you are unsure about proper attribution, please contact Us at permissions@intechopen.com.
\\n\\nIn the event that you use more than one of IntechOpen's Works published in one or more books (but not a significant part of the book that is under separate Copyright), each of these have to be properly attributed in the way described.
\\n\\nIntechOpen does not have any claims on newly created copyrighted Works, but the Works originally published by IntechOpen must be properly attributed.
\\n\\nAll these rules apply to BOTH online and offline use.
\\n\\nParts of the Rules of Attribution are based on Work Attributing Creative Commons Materials published by the Australian Research Council Centre of Excellence for Creative Industries and Innovation, in partnership with Creative Commons Australia, which can be found at creativecommons.org.au licensed under Creative Commons Attribution 2.5 Australia license, and Best practices for attribution published by Creative Commons, which can be found at wiki.creativecommons.org under the Creative Commons Attribution 4.0 license.
\\n\\nAll the above rules are subject to change, IntechOpen reserves the right to take appropriate action if any of the conditions outlined above are not met.
\\n\\nPolicy last updated: 2016-06-09
\\n"}]'},components:[{type:"htmlEditorComponent",content:'Work - a book Chapter (as well as Conference Papers), including any and all content, graphics, images and/or other materials forming part of, or accompanying, the Chapter/Conference Paper.
\n\nAttribution – appropriate credit for the used Work or book.
\n\nCreative Commons licenses – enable licensors to retain copyright while allowing others to use their Works in an appropriate way.
\n\nRules of Attribution for Works Published by IntechOpen
\n\nWith the purpose of protecting Authors' copyright and the transparent reuse of OA (Open Access) content, IntechOpen has developed Rules of Attribution of Works licensed under Creative Commons licenses.
\n\n\n\t- All Chapters published in IntechOpen books prior to October 2011 are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported license (CC BY-NC-SA 3.0);
\n\t- All Chapters published in IntechOpen books after October 2011 are licensed under the Creative Commons Attribution 3.0 Unported license (CC BY 3.0);
\n
\n\nIn case you reuse or republish any of the Works licensed under CC licenses, you must abide by the guidelines outlined below:
\n\n1. Rules for reusing of books in their entirety or significant parts of books
\n\nAll rights to Books and other compilations published on the IntechOpen platform and in print are reserved by IntechOpen. The Copyright to Books and other compilations is subject to a separate Copyright from any that exists in the included Works.
\n\nA Book in its entirety or a significant part of a Book cannot be translated freely without specific written consent by the publisher. Further information can be obtained at permissions@intechopen.com.
\n\nIn instances where permission is obtained from the publisher for reusing or republishing the Book, or significant parts of the Book, all of the following conditions apply:
\n\n\n\t- Information about the first publisher must be provided – please note the fact that the material was originally published by IntechOpen as an OA (Open Access) publication must be acknowledged;
\n\t- All original Academic Editor(s) must be credited;
\n\t- Since you are reusing content that someone else created and allowed you to use freely, you must credit all Authors involved;
\n\t- The type of license that is available for the Works must be indicated, as well as a link to the license provided, so that others can investigate the terms of the license. You will be aware that the material can be used for free in consequence of the CC license attribution, so you must acknowledge that fact. It is not sufficient that the material is Creative Commons, because that says nothing about how the material can actually be used. There are different CC licenses and you have to identify the specific license that is being used;
\n\t- Any original Copyright Notices associated, with the Works which constitute the Book must be kept intact;
\n\t- Provision of the original title of the Book, as well as the original titles of any individual Works;
\n\t- Provision of the URL where the Book is hosted, with a notice to the effect that the Book is an OA (Open Access) publication;
\n\t- Provision of the URL to every individual Work which constitutes the Book with a notice that the Work is an OA (Open Access) publication. As the material has been accessed for free, it is incumbent upon you to provide the source so that others can also access it for free.
\n
\n\nEvery single Work that is used has to be attributed in the way described. If you are unsure about proper attribution, please write to permissions@intechopen.com.
\n\n2. Rules of attribution for works published by IntechOpen
\n\nIndividual Works originally published in IntechOpen books are licensed under Creative Commons licenses and can be freely used under terms of the respective CC license, if properly attributed. In order to properly attribute the Work you must respect all the conditions outlined below:
\n\n\n\t- Credit all Authors – since you are reusing contents that someone created and allowed you to use freely, you have to acknowledge authorship;
\n\t- Indicate the type of license under which the Work is available and provide the URL to the license so others can find out the license terms. Preferably keep intact any original Copyright Notice associated with the Chapter (if any). You will be aware that the material can be used for free in consequence of the CC license attribution, so you must acknowledge that fact. It is not sufficient that the material is Creative Commons, because that says nothing about how the material can actually be used. There are different CC licenses and you have to identify the specific license that is being used;
\n\t- Provide the URL where the Work is hosted, preferably providing the original title of the Work, as well as the original title of the Book with a notification that the Work is an OA (Open Access) publication. As the material has been accessed for free, it is incumbent upon you to provide the source so that others can also access it for free;
\n\t- Provide information about the first publisher – please note the fact that the material was originally published by IntechOpen as an OA (Open Access) Work must be acknowledged.
\n
\n\nEvery single Work that is used has to be attributed in the way as described. If you are unsure about proper attribution, please contact Us at permissions@intechopen.com.
\n\nIn the event that you use more than one of IntechOpen's Works published in one or more books (but not a significant part of the book that is under separate Copyright), each of these have to be properly attributed in the way described.
\n\nIntechOpen does not have any claims on newly created copyrighted Works, but the Works originally published by IntechOpen must be properly attributed.
\n\nAll these rules apply to BOTH online and offline use.
\n\nParts of the Rules of Attribution are based on Work Attributing Creative Commons Materials published by the Australian Research Council Centre of Excellence for Creative Industries and Innovation, in partnership with Creative Commons Australia, which can be found at creativecommons.org.au licensed under Creative Commons Attribution 2.5 Australia license, and Best practices for attribution published by Creative Commons, which can be found at wiki.creativecommons.org under the Creative Commons Attribution 4.0 license.
\n\nAll the above rules are subject to change, IntechOpen reserves the right to take appropriate action if any of the conditions outlined above are not met.
\n\nPolicy last updated: 2016-06-09
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[],filtersByRegion:[],offset:0,limit:12,total:null},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"1",sort:"ebgfFaeGuveeFgfcChcyvfu"},books:[],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:43},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:12},{group:"topic",caption:"Business, Management and Economics",value:7,count:4},{group:"topic",caption:"Chemistry",value:8,count:24},{group:"topic",caption:"Computer and Information Science",value:9,count:19},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:19},{group:"topic",caption:"Engineering",value:11,count:65},{group:"topic",caption:"Environmental Sciences",value:12,count:9},{group:"topic",caption:"Immunology and Microbiology",value:13,count:11},{group:"topic",caption:"Materials Science",value:14,count:29},{group:"topic",caption:"Mathematics",value:15,count:11},{group:"topic",caption:"Medicine",value:16,count:127},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:9},{group:"topic",caption:"Neuroscience",value:18,count:3},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:6},{group:"topic",caption:"Physics",value:20,count:12},{group:"topic",caption:"Psychology",value:21,count:9},{group:"topic",caption:"Robotics",value:22,count:3},{group:"topic",caption:"Social Sciences",value:23,count:9},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:3}],offset:0,limit:12,total:null},popularBooks:{featuredBooks:[],offset:0,limit:12,total:null},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[],latestBooks:[]},subject:{topic:{id:"561",title:"Signal Processing",slug:"computer-science-and-engineering-signal-processing",parent:{id:"90",title:"Computer Science and Engineering",slug:"computer-science-and-engineering"},numberOfBooks:4,numberOfSeries:0,numberOfAuthorsAndEditors:183,numberOfWosCitations:104,numberOfCrossrefCitations:103,numberOfDimensionsCitations:197,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"561",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"4655",title:"Applications of Digital Signal Processing through Practical Approach",subtitle:null,isOpenForSubmission:!1,hash:"b20308efd28e8a487949997c8d673fb8",slug:"applications-of-digital-signal-processing-through-practical-approach",bookSignature:"Sudhakar Radhakrishnan",coverURL:"https://cdn.intechopen.com/books/images_new/4655.jpg",editedByType:"Edited by",editors:[{id:"26327",title:"Dr.",name:"Sudhakar",middleName:null,surname:"Radhakrishnan",slug:"sudhakar-radhakrishnan",fullName:"Sudhakar Radhakrishnan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"599",title:"Applications of Digital Signal Processing",subtitle:null,isOpenForSubmission:!1,hash:"0806065a04f7ecc14f1c45a0b0127638",slug:"applications-of-digital-signal-processing",bookSignature:"Christian Cuadrado-Laborde",coverURL:"https://cdn.intechopen.com/books/images_new/599.jpg",editedByType:"Edited by",editors:[{id:"29543",title:"Dr.",name:"Christian",middleName:"A",surname:"Cuadrado-Laborde",slug:"christian-cuadrado-laborde",fullName:"Christian Cuadrado-Laborde"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3175",title:"Signal Processing",subtitle:null,isOpenForSubmission:!1,hash:"25238b9acd5326ed3e8b349570f47c0d",slug:"signal-processing",bookSignature:"Sebastian Miron",coverURL:"https://cdn.intechopen.com/books/images_new/3175.jpg",editedByType:"Edited by",editors:[{id:"1053",title:"Dr.",name:"Sebastian",middleName:null,surname:"Miron",slug:"sebastian-miron",fullName:"Sebastian Miron"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3184",title:"Recent Advances in Signal Processing",subtitle:null,isOpenForSubmission:!1,hash:"a12827ec504927d4c493d8add2079d8c",slug:"recent-advances-in-signal-processing",bookSignature:"Ashraf A Zaher",coverURL:"https://cdn.intechopen.com/books/images_new/3184.jpg",editedByType:"Edited by",editors:[{id:"1729",title:"Dr.",name:"Ashraf",middleName:null,surname:"Zaher",slug:"ashraf-zaher",fullName:"Ashraf Zaher"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:4,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"9252",doi:"10.5772/7447",title:"Contact-free Hand Biometric System for Real Environments Based on Geometric Features",slug:"contact-free-hand-biometric-system-for-real-environments-based-on-geometric-features",totalDownloads:2469,totalCrossrefCites:12,totalDimensionsCites:35,abstract:null,book:{id:"3184",slug:"recent-advances-in-signal-processing",title:"Recent Advances in Signal Processing",fullTitle:"Recent Advances in Signal Processing"},signatures:"Aythami Morales and Miguel A. Ferrer",authors:[{id:"1659",title:"Mr.",name:"Aythami",middleName:null,surname:"Morales Moreno",slug:"aythami-morales-moreno",fullName:"Aythami Morales Moreno"},{id:"42778",title:"Mr.",name:"Miguel A.",middleName:null,surname:"Ferrer",slug:"miguel-a.-ferrer",fullName:"Miguel A. Ferrer"}]},{id:"9251",doi:"10.5772/7448",title:"Supervised Crack Detection and Classification in Images of Road Pavement Flexible Surfaces",slug:"supervised-crack-detection-and-classification-in-images-of-road-pavement-flexible-surfaces",totalDownloads:3297,totalCrossrefCites:19,totalDimensionsCites:26,abstract:null,book:{id:"3184",slug:"recent-advances-in-signal-processing",title:"Recent Advances in Signal Processing",fullTitle:"Recent Advances in Signal Processing"},signatures:"Henrique Oliveira and Paulo Lobato Correia",authors:[{id:"1350",title:"Prof.",name:"Paulo",middleName:null,surname:"Correia",slug:"paulo-correia",fullName:"Paulo Correia"},{id:"1783",title:"Prof.",name:"Henrique",middleName:null,surname:"Oliveira",slug:"henrique-oliveira",fullName:"Henrique Oliveira"}]},{id:"9254",doi:"10.5772/7446",title:"Suppression of Correlated Noise",slug:"suppression-of-correlated-noise",totalDownloads:5805,totalCrossrefCites:3,totalDimensionsCites:10,abstract:null,book:{id:"3184",slug:"recent-advances-in-signal-processing",title:"Recent Advances in Signal Processing",fullTitle:"Recent Advances in Signal Processing"},signatures:"Jan Aelterman, Bart Goossens, Aleksandra Pizurica and Wilfried Philips",authors:[{id:"1591",title:"Dr.",name:"Jan",middleName:null,surname:"Aelterman",slug:"jan-aelterman",fullName:"Jan Aelterman"},{id:"52263",title:"Prof.",name:"Aleksandra",middleName:null,surname:"Pizurica",slug:"aleksandra-pizurica",fullName:"Aleksandra Pizurica"},{id:"52264",title:"Prof.",name:"Wilfried",middleName:null,surname:"Philips",slug:"wilfried-philips",fullName:"Wilfried Philips"},{id:"86849",title:"Dr.",name:"Bart",middleName:null,surname:"Goossens",slug:"bart-goossens",fullName:"Bart Goossens"}]},{id:"9256",doi:"10.5772/7444",title:"Speech Enhancement Based on Iterative Wiener Filter Using Complex LPC Speech Analysis",slug:"speech-enhancement-based-on-iterative-wiener-filter-using-complex-lpc-speech-analysis",totalDownloads:3058,totalCrossrefCites:5,totalDimensionsCites:9,abstract:null,book:{id:"3184",slug:"recent-advances-in-signal-processing",title:"Recent Advances in Signal Processing",fullTitle:"Recent Advances in Signal Processing"},signatures:"Keiichi Funaki",authors:[{id:"1315",title:"Prof.",name:"Keiichi",middleName:null,surname:"Funaki",slug:"keiichi-funaki",fullName:"Keiichi Funaki"}]},{id:"9248",doi:"10.5772/7453",title:"Protecting the Color Information by Hiding it",slug:"protecting-the-color-information-by-hiding-it",totalDownloads:1832,totalCrossrefCites:9,totalDimensionsCites:8,abstract:null,book:{id:"3184",slug:"recent-advances-in-signal-processing",title:"Recent Advances in Signal Processing",fullTitle:"Recent Advances in Signal Processing"},signatures:"Marc Chaumont and William Puech",authors:[{id:"1345",title:"Dr.",name:"Marc",middleName:null,surname:"Chaumont",slug:"marc-chaumont",fullName:"Marc Chaumont"},{id:"18640",title:"Prof.",name:"William",middleName:null,surname:"Puech",slug:"william-puech",fullName:"William Puech"}]}],mostDownloadedChaptersLast30Days:[{id:"48835",title:"Application of DSP in Power Conversion Systems — A Practical Approach for Multiphase Drives",slug:"application-of-dsp-in-power-conversion-systems-a-practical-approach-for-multiphase-drives",totalDownloads:3219,totalCrossrefCites:1,totalDimensionsCites:1,abstract:"Digital Signal Processing is not a recent research field, but has become a powerful technology to solve engineering problems in the last few decades due to the introduction by Texas Instruments in 1982 of the Digital Signal Processor. Fast digital signal processors have quickly become a cornerstone of high-performance electrical drives, where power electronic conversion systems have heavy online computation burdens and must be controlled using complex control algorithms. In this sense, multiphase drives represent a particularly interesting case of study, where the computational cost highly increases with each extra phase. This technology has been recognized in recent times as an attractive electrical drive due to its usefulness in traction, more-electric aircraft applications and wind power generation systems. However, the complexity of the required control algorithms and signal processing techniques notably increases in relation with conventional three-phase drives. This chapter makes a revision of the necessities of a high-performance multiphase drive from the digital signal processing perspective. One of the most powerful Texas Instruments’ digital signal processor (TMS320F28335) is used, and specific control algorithms, electronic circuits and acquisition processing methods are designed, implemented and analyzed to show its interest in the development of a high-performance multiphase drive.",book:{id:"4655",slug:"applications-of-digital-signal-processing-through-practical-approach",title:"Applications of Digital Signal Processing through Practical Approach",fullTitle:"Applications of Digital Signal Processing through Practical Approach"},signatures:"Hugo Guzman, Mario Bermúdez, Cristina Martín, Federico Barrero\nand Mario Durán",authors:[{id:"174330",title:"Dr.",name:"Hugo",middleName:null,surname:"Guzmán",slug:"hugo-guzman",fullName:"Hugo Guzmán"},{id:"174607",title:"Dr.",name:"Federico",middleName:null,surname:"Barrero",slug:"federico-barrero",fullName:"Federico Barrero"},{id:"174608",title:"Dr.",name:"Mario",middleName:null,surname:"Durán",slug:"mario-duran",fullName:"Mario Durán"},{id:"175630",title:"Mr.",name:"Mario",middleName:null,surname:"Bermúdez",slug:"mario-bermudez",fullName:"Mario Bermúdez"},{id:"175631",title:"Ms.",name:"Cristina",middleName:null,surname:"Martín",slug:"cristina-martin",fullName:"Cristina Martín"}]},{id:"24300",title:"Complex Digital Signal Processing in Telecommunications",slug:"complex-digital-signal-processing-in-telecommunications",totalDownloads:12032,totalCrossrefCites:0,totalDimensionsCites:0,abstract:null,book:{id:"599",slug:"applications-of-digital-signal-processing",title:"Applications of Digital Signal Processing",fullTitle:"Applications of Digital Signal Processing"},signatures:"Zlatka Nikolova, Georgi Iliev, Miglen Ovtcharov and Vladimir Poulkov",authors:[{id:"18206",title:"Dr.",name:"Vladimir",middleName:null,surname:"Poulkov",slug:"vladimir-poulkov",fullName:"Vladimir Poulkov"},{id:"21534",title:"Dr.",name:"Georgi",middleName:null,surname:"Iliev",slug:"georgi-iliev",fullName:"Georgi Iliev"},{id:"21536",title:"Associate Prof.",name:"Zlatka",middleName:null,surname:"Valkova-Jarvis",slug:"zlatka-valkova-jarvis",fullName:"Zlatka Valkova-Jarvis"},{id:"71205",title:"MSc.",name:"Miglen",middleName:null,surname:"Ovtcharov",slug:"miglen-ovtcharov",fullName:"Miglen Ovtcharov"}]},{id:"49264",title:"Application of DSP Concept for Ultrasound Doppler Image Processing System",slug:"application-of-dsp-concept-for-ultrasound-doppler-image-processing-system",totalDownloads:2157,totalCrossrefCites:0,totalDimensionsCites:0,abstract:"Blood-flow measurements using Doppler ultrasound system are popular in ultrasonic diagnoses. But the blood-flow measurement inside the heart is difficult. There are many reasons behind it. The deep range and fast blood-flow are difficult to measure because of limitation of acoustic velocity. Moreover, strong heart valve signals mix into the blood-flow signal. Against such difficulties, the statistics mathematical model was applied to analyze many clinical data sets. The system identification method based on the mathematical model could realize a new blood-flow measurement system that has ultrasound Doppler information as input and electrocardiogram as output.",book:{id:"4655",slug:"applications-of-digital-signal-processing-through-practical-approach",title:"Applications of Digital Signal Processing through Practical Approach",fullTitle:"Applications of Digital Signal Processing through Practical Approach"},signatures:"Baba Tatsuro",authors:[{id:"65121",title:"Dr.",name:"Baba",middleName:null,surname:"Tatsuro",slug:"baba-tatsuro",fullName:"Baba Tatsuro"}]},{id:"24302",title:"Multiple-Membership Communities Detection and Its Applications for Mobile Networks",slug:"multiple-membership-communities-detection-and-its-applications-for-mobile-networks",totalDownloads:4079,totalCrossrefCites:4,totalDimensionsCites:4,abstract:null,book:{id:"599",slug:"applications-of-digital-signal-processing",title:"Applications of Digital Signal Processing",fullTitle:"Applications of Digital Signal Processing"},signatures:"Nikolai Nefedov",authors:[{id:"66756",title:"Dr.",name:"Nikolai",middleName:null,surname:"Nefedov",slug:"nikolai-nefedov",fullName:"Nikolai Nefedov"}]},{id:"49358",title:"Optical Signal Processing for High-Order Quadrature- Amplitude Modulation Formats",slug:"optical-signal-processing-for-high-order-quadrature-amplitude-modulation-formats",totalDownloads:1974,totalCrossrefCites:0,totalDimensionsCites:0,abstract:"In this book chapter, optical signal processing technology, including optical wavelength conversion, wavelength exchange and wavelength multicasting, for phase-noise-sensitive high-order quadrature-amplitude modulation (QAM) signals will be discussed. Due to the susceptibility of high-order QAM signals against phase noise, it is imperative to avoid the phase noise in the optical signal processing subsystems. To design high-performance optical signal processing subsystems, both linear and nonlinear phase noise and distortions are the main concerns in the system design. We will first investigate the effective monitoring approach to optimize the performance of wavelength conversion for avoiding undesired nonlinear phase noise and distortions, and then propose coherent pumping scheme to eliminate the linear phase noise from local pumps in order to realize pump-phase-noise-free wavelength conversion, wavelength exchange and multicasting for high-order QAM signals. All of the discussions are based on experimental investigation.",book:{id:"4655",slug:"applications-of-digital-signal-processing-through-practical-approach",title:"Applications of Digital Signal Processing through Practical Approach",fullTitle:"Applications of Digital Signal Processing through Practical Approach"},signatures:"Guo-Wei Lu",authors:[{id:"174507",title:"Associate Prof.",name:"Guo-Wei",middleName:null,surname:"Lu",slug:"guo-wei-lu",fullName:"Guo-Wei Lu"}]}],onlineFirstChaptersFilter:{topicId:"561",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:0,limit:8,total:null},allSeries:{pteSeriesList:[],lsSeriesList:[],hsSeriesList:[],sshSeriesList:[],testimonialsList:[]},series:{item:{id:"24",title:"Sustainable Development",doi:"10.5772/intechopen.100361",issn:null,scope:"\r\n\tTransforming our World: the 2030 Agenda for Sustainable Development endorsed by United Nations and 193 Member States, came into effect on Jan 1, 2016, to guide decision making and actions to the year 2030 and beyond. Central to this Agenda are 17 Goals, 169 associated targets and over 230 indicators that are reviewed annually. The vision envisaged in the implementation of the SDGs is centered on the five Ps: People, Planet, Prosperity, Peace and Partnership. This call for renewed focused efforts ensure we have a safe and healthy planet for current and future generations.
\r\n\r\n\t
\r\n\r\n\tThis Series focuses on covering research and applied research involving the five Ps through the following topics:
\r\n\r\n\t
\r\n\r\n\t1. Sustainable Economy and Fair Society that relates to SDG 1 on No Poverty, SDG 2 on Zero Hunger, SDG 8 on Decent Work and Economic Growth, SDG 10 on Reduced Inequalities, SDG 12 on Responsible Consumption and Production, and SDG 17 Partnership for the Goals
\r\n\r\n\t
\r\n\r\n\t2. Health and Wellbeing focusing on SDG 3 on Good Health and Wellbeing and SDG 6 on Clean Water and Sanitation
\r\n\r\n\t
\r\n\r\n\t3. Inclusivity and Social Equality involving SDG 4 on Quality Education, SDG 5 on Gender Equality, and SDG 16 on Peace, Justice and Strong Institutions
\r\n\r\n\t
\r\n\r\n\t4. Climate Change and Environmental Sustainability comprising SDG 13 on Climate Action, SDG 14 on Life Below Water, and SDG 15 on Life on Land
\r\n\r\n\t
\r\n\r\n\t5. Urban Planning and Environmental Management embracing SDG 7 on Affordable Clean Energy, SDG 9 on Industry, Innovation and Infrastructure, and SDG 11 on Sustainable Cities and Communities.
\r\n\r\n\t
\r\n\r\n\tThe series also seeks to support the use of cross cutting SDGs, as many of the goals listed above, targets and indicators are all interconnected to impact our lives and the decisions we make on a daily basis, making them impossible to tie to a single topic.
",coverUrl:"https://cdn.intechopen.com/series/covers/24.jpg",latestPublicationDate:"May 23rd, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:0,editor:{id:"262440",title:"Prof.",name:"Usha",middleName:null,surname:"Iyer-Raniga",slug:"usha-iyer-raniga",fullName:"Usha Iyer-Raniga",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRYSXQA4/Profile_Picture_2022-02-28T13:55:36.jpeg",biography:"Usha Iyer-Raniga is a professor in the School of Property and Construction Management at RMIT University. Usha co-leads the One Planet Network’s Sustainable Buildings and Construction Programme (SBC), a United Nations 10 Year Framework of Programmes on Sustainable Consumption and Production (UN 10FYP SCP) aligned with Sustainable Development Goal 12. The work also directly impacts SDG 11 on Sustainable Cities and Communities. She completed her undergraduate degree as an architect before obtaining her Masters degree from Canada and her Doctorate in Australia. Usha has been a keynote speaker as well as an invited speaker at national and international conferences, seminars and workshops. Her teaching experience includes teaching in Asian countries. She has advised Austrade, APEC, national, state and local governments. She serves as a reviewer and a member of the scientific committee for national and international refereed journals and refereed conferences. She is on the editorial board for refereed journals and has worked on Special Issues. Usha has served and continues to serve on the Boards of several not-for-profit organisations and she has also served as panel judge for a number of awards including the Premiers Sustainability Award in Victoria and the International Green Gown Awards. Usha has published over 100 publications, including research and consulting reports. Her publications cover a wide range of scientific and technical research publications that include edited books, book chapters, refereed journals, refereed conference papers and reports for local, state and federal government clients. She has also produced podcasts for various organisations and participated in media interviews. She has received state, national and international funding worth over USD $25 million. Usha has been awarded the Quarterly Franklin Membership by London Journals Press (UK). Her biography has been included in the Marquis Who's Who in the World® 2018, 2016 (33rd Edition), along with approximately 55,000 of the most accomplished men and women from around the world, including luminaries as U.N. Secretary-General Ban Ki-moon. In 2017, Usha was awarded the Marquis Who’s Who Lifetime Achiever Award.",institutionString:null,institution:{name:"RMIT University",institutionURL:null,country:{name:"Australia"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:0,paginationItems:[]},overviewPageOFChapters:{paginationCount:0,paginationItems:[]},overviewPagePublishedBooks:{paginationCount:0,paginationItems:[]},openForSubmissionBooks:{},onlineFirstChapters:{},subseriesFiltersForOFChapters:[],publishedBooks:{paginationCount:0,paginationItems:[]},subseriesFiltersForPublishedBooks:[],publicationYearFilters:[],authors:{}},subseries:{item:{id:"23",type:"subseries",title:"Computational Neuroscience",keywords:"Single-Neuron Modeling, Sensory Processing, Motor Control, Memory and Synaptic Pasticity, Attention, Identification, Categorization, Discrimination, Learning, Development, Axonal Patterning and Guidance, Neural Architecture, Behaviours and Dynamics of Networks, Cognition and the Neuroscientific Basis of Consciousness",scope:"Computational neuroscience focuses on biologically realistic abstractions and models validated and solved through computational simulations to understand principles for the development, structure, physiology, and ability of the nervous system. This topic is dedicated to biologically plausible descriptions and computational models - at various abstraction levels - of neurons and neural systems. This includes, but is not limited to: single-neuron modeling, sensory processing, motor control, memory, and synaptic plasticity, attention, identification, categorization, discrimination, learning, development, axonal patterning, guidance, neural architecture, behaviors, and dynamics of networks, cognition and the neuroscientific basis of consciousness. Particularly interesting are models of various types of more compound functions and abilities, various and more general fundamental principles (e.g., regarding architecture, organization, learning, development, etc.) found at various spatial and temporal levels.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/23.jpg",hasOnlineFirst:!1,hasPublishedBooks:!0,annualVolume:11419,editor:{id:"14004",title:"Dr.",name:"Magnus",middleName:null,surname:"Johnsson",slug:"magnus-johnsson",fullName:"Magnus Johnsson",profilePictureURL:"https://mts.intechopen.com/storage/users/14004/images/system/14004.png",biography:"Dr Magnus Johnsson is a cross-disciplinary scientist, lecturer, scientific editor and AI/machine learning consultant from Sweden. \n\nHe is currently at Malmö University in Sweden, but also held positions at Lund University in Sweden and at Moscow Engineering Physics Institute. \nHe holds editorial positions at several international scientific journals and has served as a scientific editor for books and special journal issues. \nHis research interests are wide and include, but are not limited to, autonomous systems, computer modeling, artificial neural networks, artificial intelligence, cognitive neuroscience, cognitive robotics, cognitive architectures, cognitive aids and the philosophy of mind. \n\nDr. Johnsson has experience from working in the industry and he has a keen interest in the application of neural networks and artificial intelligence to fields like industry, finance, and medicine. \n\nWeb page: www.magnusjohnsson.se",institutionString:null,institution:{name:"Malmö University",institutionURL:null,country:{name:"Sweden"}}},editorTwo:null,editorThree:null,series:{id:"14",title:"Artificial Intelligence",doi:"10.5772/intechopen.79920",issn:"2633-1403"},editorialBoard:[{id:"13818",title:"Dr.",name:"Asim",middleName:null,surname:"Bhatti",slug:"asim-bhatti",fullName:"Asim Bhatti",profilePictureURL:"https://mts.intechopen.com/storage/users/13818/images/system/13818.jpg",institutionString:null,institution:{name:"Deakin University",institutionURL:null,country:{name:"Australia"}}},{id:"151889",title:"Dr.",name:"Joao Luis Garcia",middleName:null,surname:"Rosa",slug:"joao-luis-garcia-rosa",fullName:"Joao Luis Garcia Rosa",profilePictureURL:"https://mts.intechopen.com/storage/users/151889/images/4861_n.jpg",institutionString:null,institution:{name:"University of Sao Paulo",institutionURL:null,country:{name:"Brazil"}}},{id:"103779",title:"Prof.",name:"Yalcin",middleName:null,surname:"Isler",slug:"yalcin-isler",fullName:"Yalcin Isler",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRyQ8QAK/Profile_Picture_1628834958734",institutionString:null,institution:{name:"Izmir Kâtip Çelebi University",institutionURL:null,country:{name:"Turkey"}}}]},onlineFirstChapters:{paginationCount:0,paginationItems:[]},publishedBooks:{paginationCount:0,paginationItems:[]},testimonialsList:[{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}},{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.png",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}},{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}}]},submityourwork:{pteSeriesList:[],lsSeriesList:[],hsSeriesList:[],sshSeriesList:[],subseriesList:[],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:null},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"chapter.detail",path:"/chapters/43962",hash:"",query:{},params:{id:"43962"},fullPath:"/chapters/43962",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()